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The purpose of this study was to investigate the chemotherapeutic properties of 
marine derived glycosaminoglycans (GAGs) and investigate their mechanism(s) of 
action. The secondary purpose was to investigate differences between the already 
studied cockle derived GAGs and prawn derived GAGs. 
 Nuclear magnetic resonance (NMR) spectroscopy was employed to identify 
differences between the prawn and cockle derived GAGs. External monosaccharide 
and disaccharide analysis was also performed on the prawn GAGs. The MTT assay 
was employed to also investigate the chemotherapeutic differences between the two 
derived GAGs on K562 cancer cells. Furthermore, the MTT assay was employed to 
investigate the chemotherapeutic properties of the prawn derived GAGs on healthy 
and cancer cell lines other than K562. The final aspect of this investigation was using 
affinity chromatography to separate the cellular proteins that bind to the GAGs and to 
isolate and visualise them using sodium dodecyl sulfate polyacrylamide gel 
electrophoresis (SDS-PAGE). 
The NMR spectroscopy showed the prawn extract to be a less complex extract than 
the cockle derived GAGs. The prawn GAGs also had an additional hydrogen 
environment at 2.5-3.0 ppm which could be of interest. The MTT assays showed that 
on K562 cells, cockle derived GAGs had an IC50 2.2 times lower than the prawn 
derived GAGs but both were both chemotherapeutic. The MTT investigation of the 
small sample size of cells overall insinuated a trend of GAGs being more cytotoxic 
towards cancer cells than healthy cells. Finally, on the SDS-PAGE gel, two individual 




To conclude, further investigations on prawn derived GAGs should be undertaken as 
they show potential to be a successful chemotherapeutic. Also, successful isolation 
of high specific binding proteins provide a base for an in-depth investigation into the 




















Glycosaminoglycans (otherwise known as GAGs) have long been of interest to 
researchers in a multitude of branches of science, especially drug design and 
discovery. GAGs are widely prevalent in the natural environment and have multiple 
mechanisms of action and uses ranging from angiogenesis, molecular recognition 
and interacting with growth factors amongst others (Lacetera, Galante, Jimenez-
Barbero and Martin-Santamaria, 2016). GAGs are unbranched polysaccharides that 
are added to a protein core via the Golgi apparatus in a cell to form proteoglycans. 
GAGs consist of repeating disaccharides of a uronic acid and an amino sugar, with 
the uronic acid being substituted with sulfate groups (Slack, 2014).  They are usually 
linear and sulphated with usual molecular weights between 10-100 kilodaltons (Kitic 
et al, 2016). Mammalian GAGs have been subject of many studies into their 
medicinal properties but for the first time in a recent research paper (Aldairi, 
Ogundipe and Pye, 2018) marine GAGs derived from shellfish were proven to have 
anti-cancer properties. This study aims to build upon the findings in this research 
study and build to further investigate the anti-cancer properties of these marine 
derived GAGs and to investigate why they are effective unlike their mammalian 
counterparts and if other marine sourced GAGs have similar anti-cancer properties. 
Cancer Epidemiology: 
Cancer is a worldwide major cause of illness and death. A study into the 
epidemiology of cancer found that in 2012, there was an estimated worldwide 8.2 
million deaths in relation to cancer with 14.1 million new cases being registered 
(Torre et al, 2016). Location plays a major role in the prevalence of specific types of 
cancer. In North and South America, along with north, west and south Europe, in 
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addition to Oceania, prostate cancer is the most prevalent among men, however in 
east Europe, it is lung cancer (Torre et al, 2016). 
Leukemia: 
Leukemia can be defined as a type of blood cancer that derives from the bone 
marrow. Leukemia can be sub-divided into four main groups, acute lymphoblastic 
leukemia (ALL), chronic lymphocytic leukemia (CLL), chronic myeloid leukemia 




Figure 1: A flow chart of the pathogenesis of various leukemic syndromes (Cornell 
University College of Veterinary Medicine, 2013). 
As shown in the figure above from Cornell University, a transforming event leads to 
genetic mutation(s) in a haematopoietic stem cell which can cause a variety of 
cellular developmental pathways to occur leading to the different types of leukemia. 
The four sub-groups of leukemia will be further discussed in the below sub-sections. 
6 
 
Rare germline mutations to genes such as p53, ETV6 and PAX5 can predispose 
people to the development of leukemia (Puckett and Chan, 2019). 
ALL: 
Acute lymphocytic leukemia accounts for approximately 2 percent of registered 
lymphoid neoplasms in the United States (Puckett and Chan, 2019). ALL is a 
malignancy of the T or B lymphocytes which is characterized by uncontrolled 
proliferation of immature, abnormal lymphocytes and their respective progenitors 
leading to replacement of bone marrow elements and lymphoid organs resulting in a 
distinguishable disease pattern characteristic to ALL (Puckett and Chan, 2019). ALL 
etiology is unknown however polymorphic, somatic variants of IKZF1, CDKN2A and 
ARD5B genes have been shown to have an association with an increased risk of 
ALL (Puckett and Chan, 2019). 
The common consensus on ALL is that after DNA damage, lymphoid cells 
experience uncontrolled growth and metastasise around the body and cause 
sequestration of lymphocytes and platelets in the spleen and liver which leads to 
splenomegaly and hepatomegaly (Puckett and Chan, 2019). 
AML: 
Acute myeloid leukemia is the most common malignant myeloid disorder in adults 
(20000 cases per year in the United States as of 2016 (Kouchkovsky and Abdul-Hay, 
2016)) and is defined as a heterogeneous clonal disorder of haemopoietic progenitor 
cells (Estey and Dohner, 2006). The majority of deaths with this disease are due to 
relapse; this is due to clonal evolution at the cytogenic level (Ding et al, 2012). 
The mutated genes, usually large chromosomal translocations, in AML 
predominantly effect haematopoietic proliferation and differentiation which results in 
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poorly differentiated myeloid cells accumulating (Kouchkovsky and Abdul-Hay, 
2016). 
The mutations that occur in AML have been discovered and their prevalence 
calculated. The mutations and relative prevalence are as follows; Nucleophosmin 1 
(25-30% of cases), DNA Methyltransferase 3A (18-22% of cases), Fms-Like 
Tyrosine Kinase 3 (20% of cases), Isocitrate Dehydrogenase (15-20% of cases), 
Ten-Eleven Translocation 2 (9-23% of cases), Runt-Related Transcription Factor (5-
13% of cases), CCAAT Enhancer Binding protein alpha (6-10% of cases), Additional 
Sex Comb-Like 1 (5-11% of cases), Mixed Lineage Leukemia (11% of cases), 
Tumour Protein p53 (8-14% of cases), c-KIT (less than 5% of cases) and Splicing 
factors (20% of cases) (Saultz and Garzon, 2016). 
CLL: 
In Western populations, CLL is the most common adult leukemia and can be 
characterised by the proliferation of monoclonal B cells (Taneja and Master, 2019). 
The transformation into leukemia cells is initiated by impairment of apoptosis of 
clonal B cells (Hallek, 2017). 
On a genetic level, it is believed disrupted p53 function and the over-expression of 
the ZAP-70 gene are two of the common genetic mutations that can cause CLL 
(Byrd, Stilgenbauer and Flinn, 2004). 
CLL can be easily identified due to its’ specific immunophenotyping. The typical B 
lymphocyte markers CD19, CD20 and CD23 will still be all present but in addition, 
95% of all patients with leukemia exhibit the CD5 cell surface antigen as well. (Hus 





Chronic myeloid leukemia in adults accounts for approximately 15% of all cases with 
forty percent of these patients being asymptomatic (Granatowicz et al, 2015). CML 
can be characterized by a genetic rearrangement known as the Philadelphia 
chromosome (Jabbour and Kantarijan, 2018). This is where the breakpoint cluster 
region on chromosome 22q11.2 fuses with the Abelson gene from chromosome 
9q34 (Jabbour and Kantarijan, 2018). The resultant product of this fusion is an 
oncogene known as BCR-ABL1 which causes protein translation of the oncoprotein 
BCR-ABL1 (Jabbour and Kantarijan, 2018). 
Marine Polysaccharides: 
There are a vast number of marine polysaccharides other than GAGs which can be 
extracted from marine bacteria, plants and animals. The most common and 
therapeutically used marine polysaccharides are; Ulvan, Galactan, Laminarin, 
Alginate, Fucoidan, Chitin, Chitosan, and Carrageenan (Mohan et al, 2019). When 
looking at these with an overarching broad view, they are involved in anticoagulant, 
anti-stress, antitumour, anti-inflammatory, antimicrobial, anti-stress, immunostimulant 
and antioxidant activities with also growth promotion effects (Mohan et al, 2019). 
A substantial portion of these marine polysaccharides come from seaweeds and are 




Figure 2: Bioactive sulphated marine polysaccharides from seaweed classification 
(Patel, 2012). 
Laminarin is usually extracted from brown seaweed and is a water-soluble 
polysaccharide (Ojima, 2013).  The below figure outlines the extraction process. 
 
Figure 3: Laminarin extraction process (Deleris, Nazih and Bard, 2016). 
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Laminarin can be categorised by the present degree of branching. The highly 
branched oligomers are soluble in cold water with the isomers that are less branched 
being only soluble in warm water (Spicer et al, 2017). This composes of intrachain 
β(1-6) branching that is variable depending on the environment and harvest 
conditions (Spicer et al, 2017). Once extracted, Laminarin has been shown to 
provide anti-cancer benefits by inhibiting colony formation of SK-MEL-28 and DLD-1 
cells of which both are cancerous and inducing apoptosis and inhibiting cancer cell 
proliferation in T-29 (colon) cells (Deleris, Nazih and Bard, 2016). Laminarin has also 
been shown to induce dendritic cell maturation in tumour draining lymph nodes and 
induces interferon gamma, tumour necrosis factor alpha and promotes the 
proliferation of the murine cell line OT-I and OT-II T-cells in tumours (Song et al, 
2017). 
Ulvan is a soluble fibre sourced from green seaweed and is a cell wall 
polysaccharide (Kidgell et al, 2019).  Ulvan provides anti-inflammatory effects as well 
as antioxidant effects but more importantly it also exhibits anti-cancer properties 
(Kidgell et al, 2019). A multitude of murine and human cell lines have had apoptosis 
induced by extracted Ulvan in vitro however no in vivo studies have yet to be carried 
out (Kidgell et al, 2019).  
Ulvan is also currently being researched into atherosclerosis treatment and has also 
been shown to reduce low density lipoprotein and very low-density lipoprotein 
cholesterol in rats (Patil et al, 2018). 
Chitin is the most abundant polymer produced annually after cellulose (Lodhi et al, 
2014). Chitosan is derived from the hard shells of crustaceans through degradation 
of chitin via enzymatic and acidic hydrolyses processes (Park and Kim, 2010) and 
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has potential to be used in cancer therapeutics (Babu and Ramesh, 2017). Chitosan 
has many other therapeutic uses as well which usually involve assisting other 
therapeutics. 
 
Figure 4: Medical uses of Chitosan and its’ structure (Babu and Ramesh, 2017). 
 Chitosan can be used as an absorption enhancer and in scaffold engineering for 
drug delivery (Babu and Ramesh, 2017). Regarding cancer, chitosan is an 
immunoadjuvant for vaccines and can assist in gene and chemotherapeutic delivery 
(Babu and Ramesh, 2017).  
Chitosan itself in nanoparticle form has been shown to exhibit anticancer activity in 
293 different cancerous cell types and HeLa cells when mixed with copper in a 2:5 
ratio (Adhikari and Yadav, 2018). 
When Chitin is degraded into chitooligosaccharide, the solubility greatly increases 
and it exhibits new therapeutic benefits for diseases such as diabetes, Alzheimer’s 
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and HIV-1 and has an increased absorption profile becoming completely absorbable 
in the intestinal epithelium (Naveed et al, 2019). 
Alginates are present in the cell walls of brown seaweed and alginate like 
polysaccharides can be produced as an extracellular matrix by bacteria (Nesic and 
Seslija, 2017). For medicinal purposes, alginate is regularly used to form hydrogels 
for tissue engineering, wound healing and drug delivery (Lee and Mooney, 2012). 
From a pharmaceutical aspect, alginate is used as a thickening and stabilising agent, 
especially in medicines taken via an oral dose (Lee and Mooney, 2012).  
Carrageenans are a branch of sulphated galactans that are sourced from red 
seaweed and are separated into three major types; kappa, iota and lambda (Williams 
and Phillips, 2003).  
 
Figure 5: Carrageenan differing structures. (Kariduraganavar, Kittur and Kamble, 
2014). 
Carrageenans are usually used with meat and dairy products due to them forming 
gels and their strong binding interactions with proteins but therapeutically they can 
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also be used in gel form to offer protection against HSV-2 transmission as they bind 
to the receptors on the herpes virus (Kariduruganavar, Kittur and Kamble, 2014). It 
can also be administered as a proinflammatory agent via 10% concentration in 
drinking water for 10 days (Jamwal and Kumar, 2017). This however has only been 
tested in animal models so far.  
Carrageenans are normally used to assist other therapeutics. They have high 
biocompatibility with a proportion of pharmaceuticals and can improve drug 
formulations with emphasis on prolonged drug release and can create temperature 
and pH sensitive drug delivery systems (Khan et al, 2017). 
Fucoidan is usually found in brown seaweed, in the cell wall, and some marine 
animals and has been shown to have strong anticancer properties (van Weelden et 
al, 2019). Due to the diversity of brown seaweed, fucoidan has a diverse structure 
depending on its’ source (van Weelden et al, 2019). Below is a figure illustrating the 
three most common forms. 
 
Figure 6: The three most common forms of Fucoidan. The R group can be either a 
sulfate group or a monosaccharide (van Weelden et al, 2019). 
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Fucoidan exhibits anticancer properties on a plethora of cell lines in vitro spanning 
multiple cancer types including: breast cancer, b-cell lymphoma, t-cell lymphoma, 
fibroblastic sarcoma, uterine sarcoma, lung cancer, hepatocellular carcinoma, 
colorectal cancer, keratinocytes, melanoma, bladder cancer, plasma cell myeloma, 
leukemia, stomach cancer, pancreatic cancer, ovarian cancer, endometrium 
carcinoma, prostate cancer and osteosarcoma (van Weelden et al, 2019). However, 
pharmaceutical studies have shown that as an individual treatment there are better 
alternatives, but its’ interesting use could be as a non-toxic edible product which will 
therefore be easily administered and be able to deliver the active components 
(Fitton, Stringer and Karpiniec, 2015). 
Most of these marine polysaccharides are found in seaweed. Another class of 
marine polysaccharides are GAG mimetics where the polysaccharides are not actual 
GAGs but can simulate the effects of them. These include, sulphated fucans and 
sulphated galactans. Like actual GAGs, their structure varies depending on where 





























































*All diagrams are sourced from Vasconcelos and Pomin, 2017.  
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As shown in the above table, differing species and genus of both marine algae, 
seaweed and invertebrates cause differing changes in the GAG mimetic 
polysaccharides present in the organism. This may lead to differing therapeutic 
benefits dependent on which organism the polysaccharide is extracted from. 
 
GAG Biosynthesis: 
The biosynthesis of GAGs requires activated sulfate and sugar donors, and a vast 
array of biosynthetic enzymes (Victor et al 2009). Sulfotransferases have also been 
shown to play an important role as they generate the binding sites for the proteins to 
interact with the gylocsaminoglycans (Kusche-Gullberg and Kjellen, 2003). 
Depending on the contained oligosaccharide, GAGs are synthesised via three 
biosynthetic pathways (Sasarman et al, 2016). The first biosynthetic pathway is the 
one hyaluronic acid takes, which contains no linkers and is not attached to a core 
protein (Sasarman et al, 2016). Keratan sulfate follows the biosynthetic path of 
containing up to three linkers to residues in core proteins with O-linking to serine or 
threonine and N-linking to asparagine (Sasarman et al, 2016). The most common 
biosynthetic pathway is a tetrasaccharide linker O-linked to specific serine residues 
in the core proteins which is the pathway chondroitin sulfate, heparan sulfate, 
dermatan sulfate and heparin sulfate take (Sasarman et al, 2016). 
GAG Structures: 
Once we separate the GAGs into the four major known classes, the backbone 




Figure 7: Backbone structure of GAGs (Yamada, Sugahara and Ozbek, 2011). 
These four classes of GAG along with keratan sulfate have differing distributions 
depending on what animal source they have come from. These differing distributions 
may be one of the reasons that explain why GAGs from different sources using the 




Figure 8: Distribution of GAGs based upon animal kingdom grouping (Yamada, 
Sugahara and Ozbek, 2011). 
As shown by the figure above, Crustacea, which is where the GAGs are derived from 
for this study, have a different GAG distribution than mammalian Vertebrata GAGs 
with Vertebrata having additional DS, HA and keratan sulfate which the Crustacea 
derived GAGs should not possess.  
GAG interactions: 
GAGS can interact with a variety of ligands usually through HS which can cause 
physiological changes and effects (Varki et al, 1999). These effects range from 
binding to a signalling receptor to enzyme activity regulation to protein immobilisation 
(Varki et al, 1999). Below is a table that outlines some of the major proteins that can 











Lipolysis        Inflammation/Growt
h 
Laminin Antithrombin III Lipoprotei
n lipase 
FGFs and FGF 
receptors 
 
Fibronectin Heparin cofactor II Hepatic 
lipase 














Protein c inhibitor  TGF-B 
 
 
Type V Collagen tPA and PAI-1  L and P selectins 
Vitronectin   Superoxide dismutase 
Tenascin    
 
Studies have shown that between proteins and GAGs there will be strong ionic 
interactions, however it has been shown that ionic interactions only provide 40% of 
the binding energy with 60% coming from non-ionic interactions.  (Gandhi and 
Mancera, 2008). The main forces involved are van der Waals, hydrophobic 
interactions with the carbohydrate backbone and hydrogen bonds (Gandhi and 
Mancera, 2008).  With the binding proteins, statistical analysis indicates that Asn, 
Asp, Glu, Gln, Arg, His and Trp are the most likely amino acids to be involved in 
GAG binding, especially Trp as this can form an aromatic ring which packs against 
the hydrophobic face of the GAG (Gandhi and Mancera, 2008). When breaking this 
down even further to the amino acid residues, arginine binds 2.5 times more strongly 
than lysine as the guandino group in arginine forms more stable hydrogen bonds and 




Marine GAG Structures: 
It has been reported that depending on the marine species the GAG is extracted 
from, the structure and therefore the function of the GAG differs. There is even 
variability amongst the same species with different genus having differing structures. 
Below is a table summarising different structures of marine GAGs and highlighting 
how different species and genus can alter the structure. 
Table 3: Marine GAGs and associated structures*. 










Dermatan Sulfate Ascidia nigra 
 
Dermatan Sulfate Stylea plicata  
 






   
 
*All diagrams taken from Vasconcelos and Pomin, 2017. 
As shown in the above table, even changes in the genus can affect the structural 
changes to the same GAG. Both holothurian GAGs come from different genus of sea 
cucumber and have slight structural differences. When making the change larger, 
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the Nodipectin nodosus, which is a scallop, has a much different structure of 
heparan sulfate compared to the shrimp (Litopenaeus vannamei) which contains a 
heparin/heparan sulfate hybrid instead. This may indicate variability in therapeutic 
ability depending on the source of the GAG and is something that is further 
investigated later in this study.  
 
Glycosaminoglycan Therapeutics and Cosmetics: 
Glycosaminoglycans have long been studied and developed for cosmetic and 
therapeutic uses and have been said to be ‘the most exploited carbohydrates in the 
pharmaceutical market’ (Pomin and Mulloy, 2018). The following subject will delve 
into a brief overview of the current uses of glycosaminoglycans in a therapeutic and 
cosmetic setting. 
Many glycosaminoglycans that have biological functions are side chains of 
proteoglycans and can be put into the major classes; hyaluronic acid/hyluronan (HA), 
chondroitin sulfates (CS), heparin sulphate (HS) and keratin sulphate (KS) (Volpi, 
2006). The following discussion will further explore these major groups 
independently and their current uses. 
Hyaluronic Acid: 
Hyaluronic acid is the key molecule in skin aging due to its’ unique role in retaining 
water (Papakonstantinou, Roth and Karakiulakis, 2012). HA is a non-sulphated GAG 
with a simple composition (Papakonstantinou et al, 2012). HA is a unique GAG in 
that it is not covalently attached to a protein core but it can in fact form aggregates 
with proteoglycans (Papakonstantinou et al, 2012). In biological systems, HA is 
synthesised by HA synthases, of which three varieties are found in mammals, which 
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are membrane bound proteins found on the inner surface of the plasma membrane 
which result in the release of the synthesised HA into the extracellular space 
(Papakonstantinou et al, 2012). 
Hyaluronate is also a molecule that naturally occurs in the synovial fluid and cartilage 
of mammals (Bowman et al, 2018). The main functions of this molecule differ 
between the synovial fluid and the cartilage. In the synovial fluid, it acts as a free 
radical recruiter, regulator of binding of proteins and act as a lubricant (Bowman et 
al, 2018). In the cartilage, it once again regulates the binding of proteins and acts as 
a filler of space to help keep the joints open (Bowman et al, 2018).  
As shown above, HA plays a major role in two biological systems and processes. 
Due to this, it has been researched and developed based upon its’ biological function 
to investigate whether or not it can be used as a therapeutic in the case of cartilage 
diseases and cosmetic in regard to the role in skin aging. 
Viscosupplementation (also known as intraarticular hyaluronate injection) is a non-
surgical therapy for patients under the suffering of osteoarthritis (OA) (Zhu, Lei and 
Hu, 2015). Due to HA’s role in joint lubrication, an injection of HA can provide a short 
term beefit of increased lubrication in the joint (Zhu et al, 2015). This is effective due 
to the pathogenesis of OA. OA causes the depolymerisation of endogenous HA to a 
lower molecular weight which decreases its’ viscoelastic properties (Bowman et al, 
2018). By replacing this HA with an injection it provides the patient with a short term 
supply of higher molecular weight HA until the condition of osteoarthritis causes it to 
be depolymerised again. However, this treatment has limitations based upon the 
patient. It is dependent on the levels of hyaluronidases in the patients’ synovial fluid 
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as these cleave HA into smaller pieces making degradation more efficient of HA 
(Bowman et al, 2018). 
HA is also used cosmetically in injections. Due to its’ nature as a space filler, it can 
be used to improve wrinkles and the appearance of scars, and used as a dermal 
filler. The cosmetic HA is produced by the fermentation of bacterial streptococci and 
as a result has no species specificity negating the risk of an allergy developing or 
being triggered (Andre, 2004). As it is biodegradable, no skin testing is also needed 
(Andre, 2004). The only biochemical modification that needs to be done to the 
bacterial sourced HA is stabilization to increase the half-life or to increase the ability 
to fill space (Andre, 2004). A final use of HA injections is dermis and superficial 
dermis injections to hydrate as opposed to fill the skin (Andre, 2004). 
Keratan Sulfate: 
Keratan sulphate is a naturally occurring proteoglycan (GAG bound to protein core) 
in mammals that occur in the extra-cellular matrix and on the membrane surface of 
cells (Olgierd et al, 2019). They are found in the cornea, skeleton and cerebrum and 
are divided into three major classifications KSI, KSII and KSIII accordingly (Olgierd et 
al, 2019). It is highly expressed in the bone and cartilage whereas it is not found at 
all within the mature nervous system with the exception of the cornea (Willerth, 
2017). 
Morquio syndrome is a medical condition where there is a build-up in tissues, 
specifically the cornea and cartilage, of keratin sulfate due to the deficiency of either 
beta-galactosidase or N-acetyl-galactosamine-6-sulfate sulfatase (Kumari, 2018). 
This leads to defective degradation of keratin sulphate which causes malformaties 
and mental retardation (English and Ettedgui, 2010). 
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Therapeutically, keratin sulfate could be targeted as post injury to the central 
nervous system, it is expressed and participates in glial scarring (Willerth, 2017).Glial 
scarring is a major therapeutic problem due to its inhibitory nature and blockage of 
regeneration of neurons via a chemical and physical barrier (Wang et al, 2018). 
Targeting the synthesis of keratin sulphate may allow for modifications to overcome 
or lessen these barriers (Willerth, 2017). 
Intraperitonial injection of KS has been shown to reduce cartilage damage and 
decrease cartilage fragility (Pomin, 2015). Pomin, 2015 also briefly explains how KS 
plays a role in Burkitt’s Lymphoma which is further discussed in the following section 
on current uses of GAGs in cancer. 
Chondroitin Sulfate: 
A major component of the ECM in nearly all connective tissues is chondroitin 
sulphate (Henrotin et al, 2010). 
In vitro, CS has been shown to inhibit synthesis of nitric oxide synthase, microsomal 
prostaglandin synthase and cyclooxygenase which are all inflammatory 
intermediates (Henrotin et al, 2010). Due to this inhibition, chondroitin sulfate can be 
used as a treatment for osteoarthritis. It has also been shown to act upon toll like 
receptor 4 to inhibit inflammatory cytokines and tumour necrosis factor (Henrotin et 
al, 2010). 
Heparan Sulfate: 
Heparan sulfate chains covalently attach to a core protein to form heparin sulfate 
proteoglycans which are glycoproteins found in the extracellular matrix and at the 
cell surface (Sarrazin, Lamanna and Esko, 2011).  
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The main and most well-known use of heparin sulfate is the use of heparin as an 
anti-coagulant which is usually administered subcutaneously or parenterally with 
ongoing research into oral administration (Paliwal et al, 2012). These are usually 
unfractionated and/or low molecular weight (Paliwal et al, 2012). 
Heparin plays a role in taupathologies such as Pick’s disease, Alzheimer’s disease 
and progressive supranuclear palsy (Naini and Soussi-Yannicostas, 2018). These 
diseases are caused by hyperphosphorylation and aggregation of microtubule-
associated protein tau (MAPT) (Naini and Soussi-Yannicostas, 2018).  The 
discovered tau aggregates are associated with heparin sulfates which are highly 
sulphated polysaccharides (Naini and Soussi-Yannicostas, 2018). Potential 
therapeutics regarding this are being investigated, with emphasis on targeting 
Heparinase and Heparinase 2 (Lorente-Gea etal, 2017). 
Current Cancer Treatments: 
Currently, there is a plethora of cancer treatments that can be used individually or as 
a combination. These include but are not limited to; radiation, chemotherapy, 
surgery, immunotherapy and targeted treatments (Huang et al, 2017). 
Radiotherapy: 
Approximately two thirds of cancer patients undergo radiotherapy as part of their 
cancer treatment plan (Berkey, 2010). The basic principle behind radiation therapy 
(known as radiotherapy or RT) is the usage of ionizing radiations to treat 
malignancies (Mehta et al, 2011). The cellular death pathway/mechanism due to 
radiation therapy is an area of interest still under study by many scientists globally, 
however, the main consensus is that the radiation causes double stranded breaks in 
the DNA (deoxyribose nucleic acid) in the cancerous/targeted cells (Mehta et al, 
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2011). In a clinical situation, the radiation damage is caused indirectly due to 
radiolysis of the cellular water which forms free radical intermediaries (Mehta et al, 
2011). The overall goal of radiation therapy is to maximize the radiation exposure to 
cancerous cells whilst minimizing the exposure to normal cells (Baskar et al, 2012). 
Differential cancer cell death is usually achieved due to the differences in the rate of 
repair between healthy and cancer cells (Baskar et al, 2012). Cancer cells are much 
less efficient at repairing themselves after cellular damage than their healthy 
counterparts (Baskar et al, 2012). 
Radiotherapy, like the majority of current cancer treatments, has a variety of adverse 
side effects. The majority of side effects from radiotherapy include; depression and 
cancer related fatigue, radiation dermatitis, cardiovascular disease, radiation 
pneumonitis, radiation esophagitis, radiation induced emesis, chronic radiation 
cystitis, and erectile dysfunction in males and vaginal stenosis in females (Berkey, 
2010). 
Immunotherapy: 
Cancer immunotherapy is a precision medicine branch of cancer therapeutics. The 
main components of cancer immunotherapy are immune checkpoint inhibitors, 
precision cancer cell killers via tumour antigen recognition (Tumour infiltrating 
lymphocytes, CAR T cells and TCR T cells) and cancer vaccines derived from 
tumour cell DNA, RNA or oncolytic viruses or patient derived dendritic cells (Liu and 
Guo, 2018). 
Cancer cells can activate multiple immune checkpoint pathways that have 
immunosuppressive functions (Darvin et al, 2018). Monoclonal antibodies can target 
these checkpoints and negate the activation by the cancer cells (Darvin et al, 2018). 
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So far, PD-1/PD-L1 and CTLA-4 inhibitors have shown positive results in recent 
studies (Darvin et al, 2018). 
Tumour infiltrating lymphocytes are found in tumours, leading to the hypothesis that 
tumours cause an immune response in the patient which is mediated by tumour 
antigens which in turn distinguish the cancer cells from the healthy cells and 
therefore provide an immunological target (Gooden et al, 2011).  
TCR-T cells are engineered T cells that can mediate tumour lysis and eradication 
due to the engineering (Ping, Liu and Zhang, 2018). CAR T cells are engineered for 
the chimeric antigen receptors (CARs) and are more potent than TCR-T cells but are 
limited to membrane antigens which only represent 1% of total proteins expressed in 
the cancer cells (Walseng et al, 2017). 
Cancer vaccines promote tumour specific immune responses with emphasis on CD8 
positive T cells which show specificity to tumour antigens (Butterfield, 2015). 
Provenge, which is personalised dendritic vaccine sipuleucel-T and Prostac-VF 
which is recombinant viral prostate cancer vaccine PSA-TRICOM have been 
approved for clinical use (Thomas and Prendergast, 2016). Unlike traditional 
vaccines which provide immunity to a pathogen, cancer vaccines work to help clear 
the body of the cancerous cells (Thomas and Prendergast, 2016). 
Chemotherapy: 
Chemotherapy is the usage of cytostatic drugs either orally or intravenously which 
stop the uncontrollable division of cancer cells (IQWIG, 2016). There are four 
different types of chemotherapy; 
Adjuvant chemotherapy targets leftover undetectable cancer cells after surgery, 
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Curative chemotherapy has the aim of a complete cure from the cancer, 
Palliative chemotherapy is the alleviation of cancer effects when the disease is 
incurable, 
Neoadjuvant chemotherapy is the reduction of an inoperable cancer to allow it to be 
operated upon (IQWIG, 2016). 
Chemotherapy however is well renowned for its’ adverse side effects. The most 
common side effects of chemotherapy are as follows; chest pain, constipation, 
diarrhoea, dysnpnoea, fatigue, mucositis, pain, rashes, vomiting and hair loss 
(Pearce et al, 2017). 
Leukemia Treatments: 
Leukemia treatments can vary depending on what sub-group of leukemia the patient 
is suffering with. 
For CML, if the disease is in the chronic phase, there are four tyrosine kinase 
inhibitors that are a highly effective treatment. These are imatinib, bosutinib, 
dasatinib and nilotinib (Eden and Coviello, 2019). Generically speaking, tyrosine 
kinase inhibitors work via the mechanism of competitive ATP inhibition at the 
catalytic binding site of tyrosine kinase (Hartmann et al, 2009). However, depending 
on the inhibitor, they exhibit a range of pharmacokinetics and adverse effects 
(Hartmann et al, 2009). 
However, like most anti-chemotherapeutic drugs on the market, tyrosine kinase 
inhibitors do not come without adverse side effects. These side effects include but 
are not limited to; thrombopenia, anaemia, neutropenia, diarrhoea, vomiting, 
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oedema, nausea and hypothyroidism amongst the most common ones (Hartmann et 
al, 2009). 
ALL, like CML, can be treated with tyrosine kinase inhibitors if it is a recurrent 
malignancy (Hartmann et al, 2009). 
For CML, to prevent recurrence, central nervous system prophylaxis can be 
undertaken (Penalver et al, 2017). This is delivered via the intrathecal route targeting 
specifically the leptomeningeal compartment (Penalver et al, 2017). Alternatively, IT 
methotrexate prophylaxis can take place between chemotherapy cycles in 12mg 
doses for a total of 4-8 doses (Penalver et al, 2017). 
For some instances of AML and ALL, allogenic haematopoietic stem cell transplant 
can be a treatment option (Talati and Sweet, 2018). Initially, this treatment was used 
for patients with late-stage leukemia when all other treatments had failed, however 
recent breakthroughs in medicinal knowledge and research have made this 
treatment a potential therapeutic for a variety of haematopoietic malignancies 
(Gyurkocza, Rezvani and Storb, 2010). This treatment is the transplantation of donor 
haematopoietic stem cells to reconstitute haematopoiesis (Gyurkocza, Rezvani and 
Storb, 2010). 
Alternative research has also targeted leukemic stem cells directly. RNA interference 
or small molecule inhibition of p-21 activated kinase (PAK1) has been shown to have 
very positive effects on the inhibition of leukemia both in vitro and in vivo (Pandolfi et 
al, 2015). This is due to the identification of PAK1 being a downstream effector 
molecule for the HLX gene which is a functional gene in AML pathogenesis (Pandolfi 




Current GAGs in cancer therapeutics: 
In Burkitt’s lymphoma, keratin sulfate proteoglycans (KSPG’s) have been found to 
play a part in radiation therapy resistance (Pomin, 2015). It has been found that 
levels of GlcNAc 6-O sulfation reduce radiation induced apoptosis of the cancerous 
cells (Pomin, 2015). Potentially a combination therapy could be investigated and 
developed based upon this by combining a keratin sulfate suppressor/degrader in 
Burkitt’s lymphoma, thereby increasing susceptibility to radiation therapy, with 
radiotherapy.  
Yamada and Sugahara in 2008 explained how CS chains may be involved in tumour 
proliferation and metastasis and hypothesise how detecting and identifying these 
chains may lead to vital information to discovering new chemotherapeutics. 
Heparan sulfate mimetics is a new branch of oncological research ongoing to 
investigate how GAGs and GAG mimics can alter the role GAGs play, especially 
heparin sulfate binding proteins, in cancer growth and progression (Lanzi and 
Cassinelli, 2018). 
Method Theories: 
The next few sub-sections of the introduction outline the theories behind the 
techniques and help to elaborate as to why they were employed for this study. 
SDS-PAGE: 
Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis (SDS-PAGE) is a 
molecular biology technique/assay that is used to separate proteins between 1-
100kDa and is the most widely used method for separating proteins 30kDa in size or 
below (Schagger, 2006). Polyacrylamide gel electrophoresis is usually used to 
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separate molecules by charge and size (Brunelle and Green, 2014). SDS-PAGE 
separates protein molecules by size and does this via the presence of SDS which is 
a denaturing detergent which affects secondary and nondisulfide-linked tertiary 
structures by coating them with a negative charge in correlation with the length of the 
protein molecule (Bruelle and Green, 2014). 2-mercaptoethanol is present in the 
loading buffer with the samples as a reducing agent which reduces the dislufide 
bonds present (MBL Life Science, 2017). The combination of both of these 
chemicals present in the loading buffer linearize the protein molecule into a 








Figure 9: A graphic showing how 2-mercaptoethanol and sodium dodecyl sulphate 
reduce and linearize the protein molecules to be used on an SDS polyacrylamide gel 
(MBL Life Science, 2017).  
The variation of SDS-PAGE used in the protocol later detailed used both a stacking 
gel and a resolving gel. The stacking gel has a lower concentration of polyacrylamide 
(4% for this study) and a different pH which allows the proteins to migrate through 
the gel faster and for a thin, concise band (Brunelle and Green, 2014). The resolving 
gel contains a higher concentration of polyacrylamide and like its’ namesake, 
resolves the proteins by separating them according to size. Smaller proteins migrate 
faster through the gel and larger proteins migrate slower, resulting in separation of 





Affinity chromatography is a biochemical technique in which the reversible bio 
specific interactions between a ligand and the corresponding molecular species are 
used to separate said species from the biological milieu being studied (Mayers and 
Carel, 1998). The principle behind affinity chromatography is similar to most 
chromatography techniques. Affinity chromatography is usually performed in small 
columns (Goding, 1996). In the instance of this research investigation, the stationary 
phase the columns were packed with was affi-gel 10 beads that had been linked with 
the prawn derived GAGs. 
The stationary phase is the component in chromatography which enables the 
separation of the components in the sample added. The stationary phase will always 
be a solid phase or a solid support with an absorbed liquid layer (Coskun, 2016).  
Affi-gel 10 requires a ligand with a free alkyl or aryl amino group to couple with it. 
Due to the extraction process of the prawn derived GAGs, the GAGs are attached to 
small protein units that had been ‘chopped’ up by the alcalase enzyme in the 
extraction procedure. This protein core provides the free amino group which then 
displaces the N-hydroxysuccinimide and forms a stable amide bond (Bio-Rad, 2019). 
The coupling of the ligands to the affi-gel beads is dependent on various factors that 
increase or decrease coupling efficiency. Affi-gel 10 is optimised for coupling the 
ligands near or below their isoelectric point (Bio-Rad, 2019). 
Temperature for ligand coupling should always be kept at 4 degrees Celsius as this 
will not denature the ligands and also slows down the reaction rate to ensure a 
controlled coupling procedure.  
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The other two major factors are coupling time and ligand concentration. Coupling 
should always be attempted in saturation to ensure a maximum coupling 
concentration has taken place. Coupling usually is fully completed within 4 hours for 
affi-gel 10 but can be left safely overnight due to the stability of the molecules. 
Due to the way the ligands are bound to the affi-gel beads via amide bonds, the 
stationary phase now consists of a solid gel medium made up of the affi-gel beads 
that have the prawn derived GAGs branching out into the spaces between the beads 
meaning any mobile phase and samples that are passed through the solid stationary 
phase have to pass the prawn derived GAGs. 
In affinity chromatography, once the now coupled stationary phase is put inside the 
column, the sample for purification/separation is then added. In this instance, total 
cell protein lysate is added to the column in an amount equivalent to what fractions 
are to be taken. The GAGs usually bind to the cellular proteins via electrostatic 
interactions between uronic acids and negatively charged sulphate groups and via 
the proteins, positively charged amino acids (Esko, Prestegard and Linhardt, 2017). 
The excess unbound ‘free’ proteins pass through the stationary phase and exit into a 
collection eppendorf.  
The bound proteins can be eluted by altering the ionic strength of these bonds 
between the GAGs and the cellular proteins, which can be done via altering the pH 
or adding a salt solution (Coskun, 2016). The concentrations used in this study are 
discussed in both the affinity chromatography methods and discussion sections.  
Sham columns are usually employed as a negative control using an unlinked 
stationary phase as a negative control to help confirm that the results are due to the 




The MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) tetrazolium 
reduction assay is a very common cell viability assay used in laboratories and was 
the first homogenous cell viability assay that was suitable for a 96 well format and 
high-throughput screening (Riss et al, 2013). Cell viability is defined as the number 
of healthy cells in a sample, in the case of the MTT assay, this is a well on the 96 
well plate (Adan, Kiraz and Baran, 2016). To summarise this assay, viable cells that 
have an active metabolism will convert the MTT reagent via the mitochondria into a 
purple crystal known as formazan which has a near maximum absorbance at 570nm 
(Riss et al, 2013). The non-viable/dead cells will not convert the MTT reagent into 
formazan. Using a spectrophotometer, an absorbance reading at the near max can 
be recorded after the formazan is solubilised. There are many ways to solubilise 
MTT reagent such as but not limited to; DMSO, SDS, acidified isopropanol and 
dimethylformamide (Riss et al, 2013). By using controls at 100% cell viability and 0% 
cell viability, absorbance readings can be converted into a percentage of cell viability 
based upon this and be used comparatively against a multitude of differing 
experimental conditions and variables such as concentration of 
chemical/pharmaceutical added to cells, type of cells tested and media the cells are 
grown in to name a few. All this depends on other experimental conditions remaining 
consistent, especially amount of cells per well and incubation time both before 
adding the MTT reagent and afterwards. 
This assay is also used to determine the half-maximal inhibitory concentration (IC50) 
of chemotherapeutic agents and is essential for discovering the biological and 





This thesis is focused on investigating the extraction of GAGs from marine sources 
and investigating how they bind to cancerous (K562 leukemia) cells and investigate 
their potential efficacy on other cells both cancerous and healthy. 
To explore these concepts the following procedures were used; 
Chemical extraction was performed and undertaken on the common cockle 
(Cerastoderma edule) via various chemical additions and centrifugations followed 
finally by dialysis and lyophilisation with a freeze dry machine to form a soluble 
powder. 
Nuclear magnetic resonance was undertaken on the extracted sample to visualise 
the extracted compound(s). 
K562 cells were cultured and lysed to expose and make all internal and external 
components of the cell accessible for the GAGs to bind to during affinity 
chromatography. 
Affinity chromatography coupled with SDS PAGE was used to show and isolate 
which cellular proteins the GAGs were binding to and to prove specific binding was 
occurring. 
MTT assays were used on various cell lines to determine an IC50 (if applicable) of 
the extracted marine GAGs to investigate their cytotoxicity. 
External monosaccharide and disaccharide analysis was undertaken to help 
understand the components and structure of the GAG extract. 
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The following chapters present how all of this occurred and discusses the findings. 
Methods: 
GAG Extraction: 
The common cockle (Cerastoderma edule) and prawn were the marine species used 
for the GAG extraction. The purchased cockles had already been deshelled so were 
ready for defatting. The defatting occurred by incubation in acetone for 72 hours and 
then subsequently left to dry for a further 24 hours. A blender was then used to grind 
the dried defatted cockles into a soluble powder. 4 grams of this powder was 
removed and dissolved in a solution of 40ml of 0.05M sodium carbonate (pH 9.2) 
and 2mL of Alcalase enzyme. This was submersed in an oil bath set at 60 degrees 
Celsius whilst being agitated at 200rpm for 48 hours. The resulting product was 
cooled to 4 degrees Celsius and 5% trichloroacetic acid (2.1g) was added. This was 
centrifuged at 8000 rpm at 4 degrees Celsius for 20 minutes and the supernatant 
was removed and retained with the precipitate being discarded.  Triple the 
supernatant volume of ethanol was added and 5g of 5% potassium acetate was 
added per 100ml of added ethanol. This was left at 4 degrees Celsius overnight. This 
was then centrifuged at 8000rpm for 30 mins at 4 degrees Celsius and the resulting 
supernatant discarded. The precipitate was dissolved in 40mL of 0.2M NaCl and 
centrifuged again using the same settings as last time. Any insoluble material formed 
a precipitate and was removed. 0.5mL of a 5% Cetylpyridinium chloride solution (5g 
in 100mL distilled water) was mixed with the supernatant and subsequently 
centrifuged with the same settings again. Once more the precipitate was recovered 
and the supernatant discarded. This was then dissolved in 10mL of 2.5M NaCl 
solution and 5 times the volume of the sample of ethanol was added. This was 
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centrifuged at 10000rpm for 30mins at 4 degrees Celsius and then dialysed for 72 
hours. Finally, this was frozen in a freezer then placed into a freeze-dry machine 
overnight to produce a powdered GAG extract. For large scale extraction the 
measurements were scaled up accordingly. 
Nuclear Magnetic Resonance: 
The now powdered GAG was dissolved in deuterium water inside a nuclear 
magnetic resonance (NMR) tube and heated with a hairdryer to aid dissolution. This 
was then placed into an NMR machine to obtain an NMR spectrum for the extracted 
compound(s). The samples were then recovered using a rotary evaporator to 
evaporate the solvent and recover the GAG. 
Cell Culturing: 
The cell lines initially used were K562 Chronic Mylogenous Leukemia cells. These 
were cultured in RPMI-1640 medium. Additionally added to this medium was 1g/L of 
glucose and inactivated FBS. Penicillin and Streptomycin was also added to the 
medium to prevent unwanted bacterial growth. Before passaging, cells were 
observed under a microscope to confirm confluence. Cells were passaged in sterile 
cabinet and incubated in T75 flasks in an environment of 95% oxygen and 5% 
carbon dioxide at 37 degrees Celsius. K562 are suspension cells so passaging 
began with the centrifugation of the contents of the T75 flask for 5 minutes at 
1500rpm. After centrifugation the supernatant was discarded and the cell pellet was 
re-suspended in pre-warmed media in a 20ml sterile tube. The contents of this tube 
was then evenly split into T75 flasks and pre-warmed media was then added to the 
T75 flasks to make up a final volume of 25ml in each flask. These were then placed 
into the incubator until confluence was observed. The cells were also cryogenically 
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preserved at -80 degrees Celsius after being mixed with FBS once a large number of 
T75 flasks containing cells at confluence were obtained. 
Cell Lysis: 
Once the cells had achieved confluency they were lysed. The cells were centrifuged 
at 2000rpm for 5 minutes and the supernatant discarded. The pellet was then 
washed in cold PBS. This was repeated 3-5 times. The supernatant was discarded 
and 2ml of cold RIPA buffer was added to the pellet. The pellet was suspended in 
the RIPA buffer and sonicated at regular intervals whilst being incubated in ice for a 
further 5-10 minutes. The solution was then centrifuged at 14000rpm for 15 minutes 
at 4 degrees Celsius. The insoluble cell debris was then discarded and the 
supernatant frozen at -80 degrees Celsius for future use. 
Protein Quantification: 
The cell lysate could be quantified for protein present. Protein standards were made 
up using BSA (bovine serum albumin). To these standards, a uniform amount of Bio-
Rad reagent was added. The absorbance was then measured at 595nm wavelength 
in a spectrophotometer. These standards and their relative absorbance were used to 
make a standard curve. Bio-Rad reagent was then added to a set amount of cell 
lysate and its absorbance measured at 595nm wavelength. The standard curve was 
then used to quantify the amount of protein in the cell lysate. 
SDS PAGE: 
To begin with, the following was mixed together; 
This was then poured into 2 casting stands and overlaid with deionised water to form 
a flat surface. This was left for 45 minutes to set and the water poured off the top.  
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The following was then mixed together; 
Table 4: SDS-PAGE gel formula 
Reagent Measurement 
dH20 6.1ml 
0.5M Tris HCl pH 6.8 2.5ml 
30% Acrylamide Solution 1.3ml 
10% SDS 100ul 
10% Fresh APS 50ul 
TEMED (Polymerising Agent) 10ul 
TOTAL VOLUME 10ml 
 
This was then poured over the separating gel and a comb inserted into the top to 
form wells. Once again, this was left to set for 45 minutes. 
The gels were then placed into a holder inside the SDS-PAGE tank and locked into 
place to form a water-tight seal.  
SDS running buffer was poured into the inner chamber of the set-up so the gels were 
submerged. 
The protein samples were mixed with a standard SDS loading buffer in a 1:1 ratio 
and 10 microlitres of each sample was loaded into each corresponding well on the 
gel. 
The outer chamber was then filled with SDS running buffer up to the fill line and the 
experiment was left to run at a constant voltage of 200 volts for approximately 30-45 
minutes depending on the speed of travel of the samples through the gel. 
The gels were then freed from the glass plating and submerged in Oriole Fluorescent 
Gel Stain in a darkened box and left to agitate for 90-120 minutes. 
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The gels were then washed in de-ionised water and imaged in a suitable imaging 
device that had an ethidium bromide filter. 
MTT Plating and Reading 
For consistent scientific results, the MTT plates were plated at a cell density of 5000 
cells per well. 10 microliters of the cultured cells were taken and mixed in a 1:1 
dilution with Trypan Blue. 10 microliters of this mixture was then pipetted onto a C-
chip/haemocytometer.  
To begin with a total cell count was taken by counting all alive cells in the four corner 
quadrants of a C-chip. (Alternative haemocytometers will work if a corner quadrant 
corresponds to 0.1 microlitres). The average of the four was then taken. The dilution 
factor (1:1) was then accounted for to acquire a value of average alive cells per 0.1 
microlitres. This was then multiplied by a factor of 10000 to acquire the number of 
cells per millilitre and then divided by 10 to acquire the number of cells per 100 
microlitres (this is the usual standard for a 96 well plate).   
 
𝐶1𝑉1 = 𝐶2𝑉2 
Figure 10: The mathematical equation used to calculate required amount of cell 
solution volume and media needed to acquire desired cell plating density. 
Using Figure 10, C1 becomes the number of cells required per well and V1 becomes 
the volume per well. C2 becomes the number of cells per 100 microlitres recorded, 







Figure 11: The re-arranged equation to achieve a calculation to work out V2. 
Using figure 11, V2 gives the required amount of cell solution needed to be added 
per well to achieve the required number of cells per well. Subtracting this value from 
0.1 gives the amount of media needed to be added per well. A final multiplication of 
the number of wells needed was calculated to ascertain the total amount of cell 
solution mixed with fresh media to achieve desired cell plating density. 
 
Affinity Chromatography 
To begin with, Affi-Gel 10 beads were defrosted from storage. A 50mM phosphate 
buffer was concocted to achieve a buffer close to a neutral pH. The prawn derived 
GAGs were added to the 50mM phosphate buffer and this was then added to the 
affi-gel 10 beads. This coupling reaction was kept at 4 degrees Celsius overnight 
with constant gentle agitation to allow maximum coupling of the ligands with the affi-
gel 10 beads. 
A second lot of affi-gel 10 beads were also mixed with 50mM phosphate buffer in the 
same conditions but without the addition of the GAGs. This was to form a sham 
column.  
The test column was then packed with the coupled affi-gel 10 beads with the GAGs 
up to the maximum fill line and the excess liquid was drained off. The sham column 
was packed the same way but with the preparation lacking the GAGs. 
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The next stages were both repeated identically for the test column and the sham 
column. 
1 ml of total cell lysate was applied to the columns and pushed through via positive 
pressure. The liquid that eluted from the column was collected in a 1ml eppendorf. 
Five lots of 1 ml of 50mM phosphate buffer was then added and pushed through the 
stationary phase via positive pressure again and the elution collected in 1 ml 
eppendorf tubes once more.  
Three different buffers were then created all in 50mM phosphate buffer. These were 
0.2M, 0.5M and 2M NaCl respectively. 
The 0.2M NaCL 50mM phosphate buffer was then added five times in 1ml 
increments and the elution collected in a 1ml eppendorf. This was repeated for the 
0.5M and 2M buffers.  
The collected fractions from affinity chromatography were analysed to see which 
fractions contained protein. Using Bio-Rad reagent (the same reagent used in 3.5), 
the absorbance of the fractions was measured at 595nm wavelength. To achieve 
consistent readings, 100 microlitres of fraction was mixed with 200 microlitres of Bio-
Rad reagent and 700 microlitres of deionised water and incubated at room 
temperature for 5 minutes. There results were then plotted for each fraction to obtain 
a visible representation of protein present in each collected fraction.  
Monosaccharide and Disaccharide Analysis: 
For the monosaccharide and disaccharide analysis, the powdered extract was sent 
to the University of California for this procedure and the results sent back were 





For cell viability tables and raw data of UV absorbance after background absorbance 
is subtracted, please refer to the appendix. 
Comparing Prawns against Cockles: 
The corresponding results below are for the testing of prawn and cockle derived 
GAGs using an identical extraction procedure on K562 cells from the same culture 
with GAGs applied in concentrations ranging from 100 micrograms per millilitre down 







Prawn vs Cockle GAGs applied to K562 Cell Line.
















Figure 12: A comparative graph to show the dosage response of two marine derived 
GAGs on the K562 cell line using the MTT assay. 
Analysis of the dataset showed that the Prawn GAGs had an IC50 of 51.98 
micrograms per ml (44.97- 60.30 with 95%CI) in comparison to the Cockle GAGs 
which had an IC50 of 20.59 micrograms per ml (19.34-21.93 with 95% CI).  
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All data points showed a significant difference from one another with the exception of 
6.25 micrograms per ml with the IC50’s being of significant difference from one 
another.  
This data shows Cockle GAGs to be 2.52 (to 2 decimal places) times more cytotoxic 
than the Prawn GAGs.  
Alternative Cell Lines: 
The following results show the cell viabilities of the various cell lines when Prawn 
GAGs were added in concentrations ranging from 200 micrograms per ml to 0.098 
micrograms per ml (to two significant figures).  
U2OS: 





Cell viability of U2OS with prawn GAGs added.














Figure 13: A graph of U2OS cell line viability when Prawn GAGs were added and 
results recorded via the MTT assay. 
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The U2OS cell line showed an IC50 of 45.40 micrograms per ml (30.42-70.84 with 
95% CI). These results show a correlation of decreased cell viability when 
concentration of GAGs was increased.  
MDBK: 





Cell viability of MDBK with Prawn GAGs added














Figure 14: Cell viability of MDBK cells with various concentrations of Prawn GAGs 
added and results recorded via the MTT assay. 
For the MDBK cell line, an IC50 of 105.4 micrograms per ml (92.87 – 120.5 with a 
95% CI) was obtained. There was a lack of correlation between 0 and 10 
micrograms per ml with a negative correlation afterwards as cell viability decreased 













BEAS-2B Cells treated with Prawn GAGs














The BEAS-2B cell line had an IC50 of 82.01 micrograms per ml (49.44-181.5 with a 
95% CI). The graph shows a slight negative correlation with cell viability decreasing 
as Prawn GAGs concentration increases.  
An obvious outlier was identified and removed, as discussed further on in the BEAS-
2B sub-section of the discussion chapter. 





BEAS-2B Cells treated with Prawn GAGs
















Figure 15: Outlier corrected BEAS-2B MTT cell viability graph. 
This lead to a new IC50 of 71.64 micrograms per ml (45.25- 142 with 95% CI) being 
discovered. 
MOLT-4: 






















Figure 16: Cell viability graph of MOLT-4 cells with prawn GAGs added and recorded 
via the MTT assay. 
MOLT-4 showed an IC50 value of 4.627 micrograms per ml (4.274 – no upper limit 
due to the software being unable to calculate it) with no correlation before 1 
microgram per ml with a very strong correlation dropping to basal level between 1 








Quantifying cell lysate protein: 



















Figure 17: Bovine Serum Albumin Standard Curve. 
Table 5: Absorbance readings in triplicate for the K562 lysates. 
SAMPLE REPEAT 1 REPEAT 2 REPEAT 3 
Parental 0.424 0.428 0.420 
Resistant 0.468 0.478 0.458 
 
Using the standard curve for the BSA the K562 parental cell line lysate had a protein 
concentration of 6.81 mg per ml and the cisplatin resistant cell line lysate had a 

























Figure 18: K562 cell lysate affinity chromatography absorbance readings. 
The figure above shows a negative correlation that as the fraction number increased 
the amount of eluted protein decreased. There was a large spike in eluted proteins at 
fraction 3 which descends until fraction 8 with another elution spike occurring at 
fraction 11 with an overall decrease thereafter. The final five fractions which are the 
























Figure 19: K562 cell lysate affinity chromatography absorbance readings of the sham 
column. 
The figure above shows a negative correlation that as the fraction number increases 
the amount of eluted protein decreases. There was a solitary large elution spike at 
fraction 2 decreasing to a baseline reading at fraction 5. There was 3 minor spikes 
afterwards but from fraction 17 onwards there was a negligible reading representing 






Figure 20: SDS-Gel of affinity fractions, stained with Oriole Fluorescent gel stain,1-
11 with the first column on the left being fraction 11 descending to the right down to 
fraction 1. 
Fractions 1, 2 and 3 show a substantial amount of eluted proteins in comparison to 
fractions 4-11. Fractions 4-11 shows some banding and confirms the presence of 
eluted proteins. 
 
Figure 21: An inversed image of the SDS-PAGE gel for fractions 1-11. 
The inversed figure above illustrates clearly which bands of proteins have been 
eluted. Fractions 1,2 and 3 show significantly more elution of the lower molecular 
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weight proteins in comparison to fractions 4-11 which show little to no elution of the 
lower molecular weight proteins. 
 
Figure 22: Fractions 12-21 (left hand side 21 descending down to fraction 12 on the 
right) of the affinity chromatography on SDS-Gel stained with Oriole Fluorescent 
stain. 
The above figure shows elution of high molecular weight proteins across all the 
fractions which seem to be identical. Fraction 18 shows elution and separation of two 
protein bands of low molecular weight that have not been eluted in any of the other 





Figure 23: Inversed image of the SDS-PAGE gel for fractions 12-21. 
The above inversed figure illustrates fraction 18 is the only fraction to elute/separate 
the two visible protein bands. The figure also confirms the common high molecular 















Figure 24: Proton NMR (solvent suppressed) of prawn derived GAGs. 
The NMR spectra above cannot resolve individual peaks and is therefore a low 
resolution NMR spectra. The above spectra indicates six different hydrogen 
environments with analysis by sight, the integration trace however separates the 




Figure 25: Proton NMR (solvent suppressed) of Cockle derived GAGs. 
This NMR spectra cannot distinguish the individual peaks and is therefore a low 
resolution NMR spectra. The above spectra indicates three to four different hydrogen 
environments, this is confirmed by the integration trace which separates the spectra 
into three groups. Full analysis is provided in the discussion section. 
Disaccharide Analysis: 
For the disaccharide analysis the following abbreviations and their respective 





















∆HexA(2S)-GlcNH2           
∆HexA-GlcNAc(6S) 




































Table 8: Heparin Sulfate disaccharide analysis of prawn GAGs. 




























Table 9: Chondroitin Sulfate disaccharide analysis of prawn GAGs. 


















The heparin sulfate analysis shows a spread of heparin sulfate disaccharides 
present with only D0H0 not appearing. D0S6 and D2S6 are the most prominent 
disaccharides at 27.1% and 25% respectively. 
The chondroitin sulfate is dominated by the D0a4/D2a0 at 84.16%. Both D2a6 and 
D2a10 were not present in this analysis. 
For sulfation percentages, chondroitin sulfate showed 0.39% unsulfated, 0.06% with 
2-SO3 sulfation, 94.80% with 4-O-SO3 sulfation and 15.39% with 6-O-SO3 sulfation. 
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Heparin sulfate analysis showed 3.51% unsulfated, 67.1% with N-SO3 sulfation, 
52.66% with 2-O-SO3 sulfation and 75.45% with 6-O-SO3 sulfation. 
Below are the graphical representations of this analysis. 
 
Figure 26: GRIL-LCMS of Heparin Sulfate. 
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Figure 27: GRIL-LCMS of Chondroitin Sulfate.  
Monosaccharide Analysis: 
The results below are from 10 micrograms of prawn derived GAG extract. 
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Figure 28: Chromatogram of monosaccharide analysis. 
Table 10: Data represented by monosaccharide analysis chromatogram. 




































































From these results it is shown that GlcNH2 and Glc are the two largest components 
of the GAG extract with Man and Fuc being the least present. However based upon 








As an initial disclaimer, all NMR spectra were run with a H20 suppression to remove 
the H20 peak that would be present (unless otherwise stated). 
 
Figure 29: Unsuppressed spectra of proton NMR of prawn extract. 
As you can see in the figure above, without H20 suppression, a large peak is 
observed at around 4.75 parts per million which severely impacts the overall spectra 
and its’ ability to be analysed and interpreted. 
Due to the complex mixtures of both the cockle and prawn GAG extracts, both of the 
NMR’s ended up being low resolution as they could not distinguish/resolve the 
complex into individual peaks.  
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With proton NMR, a basic understanding is that the more electronegative 
components of the compound analysed cause corresponding hydrogens to shift to 
the left of the spectra with the less negatively charged components causing the 
corresponding hydrogens to not shift to the left as much. The closer to zero on the 
spectra, the less negatively charged the corresponding components to the 
hydrogens shifted. 
First of all, by analysing the integration trace and its’ corresponding values, we can 
analyse the ratio of hydrogens present that give rise to the signal.  In the cockle 
derived GAGs, there is a ratio of hydrogens of 3.14 to 68.33 to 28.53 respectively 
with 3.14 being the most electro-negatively charged and the 28.53 being the least 
electro-negatively charged. These sections were split into the shifts of approximately; 
10.0-6.5 parts per million, 5.5-3.0 ppm and 2.5-0.5 ppm.  
For the prawn derived GAGs, the integration trace separated the shifts into four 
different hydrogen environments with respective ratios of 2.79 (shift of 8.5-7.0 parts 
per million) – 58.29 (6.5-3.0 ppm) – 27.96 (3.0-2.5 ppm) – 26.24 (2.5-0.3 ppm).  
This can then be converted into percentages to make comparison between the 
samples easier.  
For the cockles, the ration and the percentages are equivalent. For the prawn 
derived GAGs, the ratio converts into percentages of; 2.42%, 50.69%, 24.31% and 
22.82% respectively.  
Upon this basic analysis of the separation of hydrogen environments, the major 
difference between the prawn and the cockle derived GAGs is the presence of a 
hydrogen environment at a shift of 3.0-2.5 parts per million that is present in the 
prawn GAGs which is not present in the cockle derived GAGs. This shift of 3.0-2.5 
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ppm is equivalent to 24.31% of the signal from the NMR caused by the hydrogens 
present in this environment. At the most electro-negatively charged aspect of the 
compound, both the cockles and the prawns are very similar with percentages of 
3.14% and 2.42% so both compounds exhibit minimal hydrogen environments of 
high electro-negativity.  
For the middle section of medium electro-negativity, despite the differences in the 
integration trace split (this is inconsequential as the lower limit of 3.0 is consistent for 
both compounds and the upper limit has minimal signal), the cockle derived GAGs 
has just under 18% more hydrogens present in this environment in comparison the 
prawn counterpart. Also at the lowest level of electro-negativity (where the 
integration trace has used almost identical limits with only a 0.2 difference on the 
lower limit), the cockle derived GAGS show just under a % increase on hydrogens 
present in this environment compared to the prawn counterparts. Overall, solely 
based upon the ratio of hydrogens observed by the integration trace of the proton 
NMR, it seems that the cockle GAGs contain more electro-negative environments 
than the prawn GAGs do. 
Using chemical NMR tables, it can be theorised what is causing the 3.0-2.5 ppm shift 
signal in the prawn GAGs. The closest match on the chemical tables is an Alkynyl 
hydrogen which has a chemical shift of 2.5-3.0 ppm on a proton NMR spectroscopy. 
 
 
Figure 30: Alkynyl hydrogen diagram drawn via ChemDrawTM. 
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Alkyl halides have a chemical shift pattern of 2.5-4.0 parts per million. However, this 
would have to be investigated for the presence of either fluorine, bromine, iodine or 
chlorine to see if it is possible for an alkyl halide to be formed. This is due to the fact 
that an Alkyl halide is a compound in which a hydrogen is replaced with a halide 
(Gal, Bucher and Burns, 2016). This potential result is of particular interest as 
halogenated marine products have been recently found to show unique bioactivity 
and to help illustrate the role of chiral alkyl halides in drug discovery (Gal, Bucher 
and Burns, 2016). Halogenation has been shown to affect bioactivity whether it be 
through ligand binding or lipophilicity through the halogenation of sp carbons (Gal, 
Bucher and Burns) and could explain the differences in chemotherapeutic effects 
between the cockles and prawn GAGs.  
 
Figure 31: Alkyl Halide diagram drawn via ChemDrawTM. 
Alcohol has a proton NMR shift of 2.5-5.0 ppm. This would fall within the scope of 
the 2.5-3.0 ppm shift of the unidentified peak but would be expected to be a lot 
broader if it was alcohol so can be ruled out. 
At the lower electro-negativity side of the spectra, even though the integration trace 
hasn’t separated it itself, the prawn NMR looks to have resolved some individual 
peaks. At the lower end of a proton NMR spectra, you find the primary, secondary 
and tertiary alkyl groups. 
Primary Alkyl groups can be found with a chemical shift pattern of 0.7-1.3 parts per 





Figure 32: Primary alkyl group drawn via ChemDrawTM. 
Secondary alkyl groups contain one less hydrogen and can be found with a chemical 
shift pattern of 1.2-1.6 parts per million. Again, this corresponds with the prawn 
NMR, with the second peak from the right at around 1.2 ppm. 
 
Figure 33: Secondary alkyl group drawn via ChemDrawTM. 
Finally, tertiary alkyl groups are found with a chemical shift pattern of 1.4-1.8 parts 
per million. This could correspond with the peak on the NMR prawn spectra of 
around 1.75-1.9 parts per million. 
 
Figure 34: Tertiary alkyl structure drawn via ChemDrawTM. 
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The cockle NMR was not able to provide such resolution, this may be down to the 
extract being a lot more complex compound(s) causing crossover between peaks 
and not allowing them to be separated. 
Overall, the prawn NMR was a lot simpler extract due to the resolution of the peaks 
and how some can be clearly defined and identified. With the cockle extract, there 
was no clear identifiable peaks which makes analysis of the compound and structure 
a lot harder and complicates future analysis. The next logical stage would be to 
investigate the efficacy of the simpler prawn extract as if that is close to the 
effectiveness of the cockles as shown in the Aldairi et al, 2018 paper, future 
investigation and development will be easier and less consuming of resources as the 
extract can be more easily investigated and fully identified. This was investigated 
below in the MTT section. 
To improve upon these results, proton NMR of a higher calibre could be employed to 
achieve a greater resolution which would lead to easier identification of peaks within 
the clusters that show little to no clearly resolved peaks. 
Disaccharide Analysis: 
The disaccharide analysis provides an insight into the composition of the GAG 
extract. Alone however, this information reveals very little. Using it comparatively 
with the cockle extract and mammalian extract in the Aldairi et al, 2018 paper, 





Table 11: Heparin Sulfate disaccharide analysis of prawn, cockle and mammalian 
GAGs. 



















































Using these results, relationships can start to be hypothesised. With the exception of 
D0H0, prawn GAGs are the only GAG studied to show a signal for all of the other 
disaccharides. Both cockles and mammalian GAGs show no result for D0H6, D2H0, 
D2A0 and D2H6.  
Mammalian GAGs have been shown to exhibit no anti-proliferative properties (Aldairi 
et al, 2018). Both prawn and cockle GAGS compose of D2A6 where mammalian 
GAGs do not. Interestingly, this study has shown cockles to have an IC50 2.2 times 
lower than the prawn GAGs on K562 leukemia cells and for this disaccharide prawns 
do compose of a lower amount. It could be hypothesised therefore that this 
disaccharide plays a major role in the anti-proliferative properties of a GAG extract. 
This would need further testing however by analysing other GAG extracts and using 
the percentage of D2A6 composing the GAG extract to be the variable tested. 
Additionally, if a digest could be designed to remove this disaccharide, the GAG 
extract after this digest from prawns and cockles could be once again tested upon 
K562 leukemia cells to see if there is a significant change in the IC50. 
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Another major difference is the presence of D0S6. Both prawn and cockle GAGs 
show this in high quantities (24-27%) whereas the mammalian GAGs show a much 
smaller composition. Again this could be hypothesised to play a major role in the 
anti-proliferative properties of GAG extracts and once again it would be 
recommended to test this as a variable or perform a digest to see if it does in fact 
affect the anti-proliferative properties. 
The final major result of note is the substantially less presence of D0A0. In the 
mammalian GAG extract, this disaccharide is the major component making up 
48.4% of the heparin sulfate disaccharides present. In cockles this is only 26.6% and 
only 3.51% in the prawn GAGs. Therefore, it could be theorised that this 
disaccharide is a potential inhibitor of the anti-proliferative properties GAG extracts 
can exhibit. Once again further study would need to be conducted as outlined with 
the previous two heparin sulfate disaccharides of interest. 
The chondroitin sulfate results can also be comparatively analysed in the same 
regard. 
Table 12: Chondroitin Sulfate disaccharide analysis of prawn, cockle and 
mammalian GAG extract. 

































Unfortunately, no results could be sourced for mammalian GAGs and the chondroitin 
sulfate disaccharide analysis. 
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With the chondroitin sulfate disaccharide analysis, the prawn GAGs appear to be 
more simple in nature as they show a very large result with 84.16% of the 
composition being D0a4/D2a0 and results of 0.39% or less for four of the seven 
disaccharides. This would help explain as to why the NMR spectra for prawns was a 
lot simpler than the overlapping complex NMR for the cockles.  
Both cockles and prawns show no presence of D2a10 so it would be safe to 
hypothesise that this chondroitin sulfate disaccharide plays no positive role in the 
anti-proliferative nature of the GAG extract. 
For both D2a4 and D2a6, only one of the extracts shows a minimal composition 
where the other extract shows none at all. Again, it could be hypothesised that these 
disaccharides do not play a major role in the anti-proliferative nature of the GAG 
extracts. 
Based upon these findings, it would be recommended to test the hypothesis that 
D0a0, D0a4, D0a6 and D0a10 are the four major contributors to the anti-proliferative 
nature of the marine GAG extracts and should be further investigated. 
Further analysis can also be conducted on the overall types of sulfation present. 
Table 13: Chondroitin sulfate sulfation type analysis. 














Clearly illustrated by the table above, cockles consist of a substantially greater 
proportion of 6-O-SO3 sulfation. The unsulfated and 2-SO3 results do not seem to 
have a significant difference from each other and it can be hypothesised these do 
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not play as much of a role in the anti-proliferative properties of the GAG extract that 
the other two types of sulfation do. As cockles have been shown to be a stronger 
anti-proliferative therapeutic on K562 cells, this could be caused by the increase in 6-
O-SO3 sulfation which may play a role in increasing the anti-proliferative properties 
or the reduction in 4-O-SO3 sulfation which may be inhibitory to the anti-proliferative 
properties. This could be investigated further with similar analysis being performed 
on mammalian GAGs to identify differences and similarities. 
Table 14: Heparin Sulfate sulfation type analysis. 














With the HS sulfation analysis, three of the four types of sulfation look to show 
significant difference from each other with only N-SO3 sulfation being similar. 
Cockles show an increase of unsulfated heparin disaccharides and a decrease in 2-
O-SO3 and 6-O-SO3 disaccharides. With more differences than similarities it cannot 
be hypothesised which sulfation could potentially be affecting the differences in anti-
proliferative activity. Theoretically it could be the combination of all three differences 
along with differences in the chondroitin sulfate disaccharides as well. With the 
similarities in the N-SO3 sulfation however, it can be hypothesised that this type of 
sulfation does not account for the difference in anti-proliferative activity between 






Aldairi et al, 2018, on which this study predominantly follows on from, used the same 
external source to perform the monosaccharide analysis on their cockle derived 
GAGs. By comparing the results between the prawns and the cockles we can begin 
to hypothesise the relationship between prawn and cockle GAGs and why there is a 
difference in anti-proliferative properties and hopefully begin to hypothesise why 
marine GAGs exhibit anti-proliferative properties where the mammalian GAGs do 
not. 
Table 15: Cockle and prawn monosaccharide analysis comparison. 


























GlcA, GlcNH2 and GalNH2 are the main monosaccharides found when acid 
hydrolysis of marine and mammalian GAG chains occur. Their presence confirms 
that the extraction process for both cockles and prawns has produces GAG chains in 
the extract.  
The major differences are the decrease of GlcNH2 in cockles, the increase of Glc in 
cockles and the presence of Xyl in prawns but not cockles. (Gal and Fuc also show 
an increase in cockles but not at the magnitude of the larger differences). 
Potentially, Xyl could be an inhibitor of anti-proliferative activity and explain the 
differences between the prawns and cockles. Subsequently, this could also be said 
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for GlcNH2. Furthermore, the difference in anti-proliferative activity could be affected 
by the presence of Glc as this may enhance the anti-proliferative nature of the 
GAGs. Without individual testing of these components it cannot accurately be 
determined which factor is contributing to the anti-proliferative activity of the marine 
derived GAGs and more than likely it is a combination of all the factors both 
monosaccharide and disaccharide differences alike.  
Overall however, both the monosaccharide and disaccharide analysis has given an 
insight into the structure of these marine derived GAGs and has showed that there is 
a structural difference between the two sources which can be hypothesised to 
account for the differences in the anti-proliferative effectiveness on K562 cancer 
cells. 
 
MTT Results:  
For all the data analysis and graphical representation of the MTT results, the 
software GraphPad was used. GraphPad is highly regarded within the scientific 
community for its’ ease of use and data representation.  
Cockle vs Prawn K562 Comparison: 
The cockle and prawn GAGs comparison was used to see if the Prawn GAGs which 
showed a much simpler structure via the NMR had the same cytotoxic effects as the 
cockle derived GAGS.  
The IC50 result for both of these as a result of the triplicate investigation showed that 
there was a siginificant difference between the results and at every single data point 
except from 6.25 micrograms per ml. These results suggest a difference in 
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cytotoxicity from the different sources of GAGs with cockles being 2.25 times more 
effective based upon this.  
An IC50 was reached however with the Prawn GAGs within the experiment 
parameters at 51.98 micrograms per ml which suggests a positive result for the 
Prawn GAGs and that they are cytotoxic towards K562 cells.  
Aldairi et al in 2018 achieved an average cytotoxicity of 4 micrograms per ml for the 
cockles but did state that there was inter-batch variability with the results with the 
extracted cockles. The results from this experiment are higher than of Aldairi et al 
2018, however, for each plate in the triplicate the same batch of derived GAGs was 
used as a bulk extraction was undertaken for this research topic. This may explain 
the higher results and could indicate a lower true IC50 for the prawn GAGs as well.  
Scrutiny of the data analysis can also be undertaken to judge the accuracy of the 
IC50 calculated. The analytical software uses a non-linear fit line of regression to 
calculate the IC50. The accuracy of this line of regression can be determined using 
the R2 value, which is the coefficient of determination. As standard, an R2 value of 
over 0.95 (maximum 1 for perfect fit) is desired and deemed to be scientifically 
accurate. However, this needs to be coupled with physically looking at the graph to 
see the closeness of fit as a high R2 value is not always a true indicator of closeness 
of fit. 
For cockles, the coefficient of determination value was 0.9631. This indicates a close 
fit of the line of regression. Upon inspection, the line of regression shows slight 
underestimation at the higher and lower concentrations which would account for the 
coefficient of determination being below 1. This suggests the IC50 from this 
experiment should therefore be accurate.  
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The prawn GAGs has a coefficient of determination of 0.8115. Upon inspection of 
the graph this seems to be due to a gross underestimation at the lowest 
concentration with the rest of the graph seeming to have a close fit. Based upon the 
coefficient of determination alone the IC50 could be suggested to not be accurate 
however coupled with visible inspection that may not be the case. 
An interesting aspect of this data is that both the cockle and prawn GAGs show cell 
growth promotion at the lowest concentration of 3.125 micrograms per ml with 
Prawns showing 30-40% cell growth promotion. The mechanism of action behind 
this is unknown and could further be investigated to see if it was an anomaly or not. 
This potential property of the GAGs was therefore monitored in the other cell lines 
tested to see if it was a recurring property.  
U2OS: 
The U2OS cell line had an IC50 of 45.40 micrograms per ml. This suggests that 
prawn GAGs are cytotoxic on this cell line. This result indicated that this cell line is 
more responsive than the K562 cell line, however, the upper limit of the U2OS 
results were higher than the upper limit of the K562 results so this cannot be 
definitively determined.  
The U2OS data points show a lot of variance so there is little significant difference 
between the data points at the various concentrations. In fact, the first indication of 
significant difference is between 200 micrograms per ml and 0.78125 micrograms 
per ml. This lower concentration also shows a significant difference when compared 
to 100 micrograms per ml.  
The coefficient of determination also helps to show the variance between the results 
with a value of 0.5719. This indicates a very loose fit for the line of regression. Upon 
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visible inspection this could be due to the underestimation of the lowest four 
concentrations and overestimation of the middle four concentrations.  
The reason for this inaccuracy could be due to the exclusion of the lower 
concentrations of plate two in the triplicate experiment due to contamination. The 6 
triplicate wells on the 96 well plate of this experiment were somehow contaminated 
and had to be excluded altogether leading to only two sets of data being used for the 
lower six concentrations where the line of regression is most inaccurate. 
To improve upon this given less time constraints, another plate could be performed 
to replace plate two in its entirety to see if better results are obtained. 
Once again, at the lowest concentration (albeit significantly lower than the 3.125 
micrograms per ml of the comparative experiment), cell growth looks to be promoted. 
However, due to the large variance the lower limit goes below 100% cell viability so 
this cannot be safely determined.  
 
MDBK: 
The MDBK cell line had an IC50 of 105.4 micrograms per ml. This shows that the 
prawn GAGs have cytotoxic effects on the cell line.  
The data points between 25 micrograms per ml and 200 micrograms per ml all 
showed significant difference from each other and individually showed very little 
variance between their own nine total readings/wells across the three triplicate 
plates. Once the cell line reached approximately 100% cell viability at 25 micrograms 
per ml the data points show no significant difference and the variance greatly 
increases. This may be causes due to the lower concentrations being prepared via 
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serial dilution leading to a greater level of inaccuracy and variation at the lower 
concentrations.  
The coefficient of determination was 0.8071 for this experiment. Upon visible 
inspection, this is most likely due to the lack of correlation and erratic nature of the 
data points at the lower concentrations of GAGs added. Once the variance 
decreases post 25 micrograms per ml added, the line of regression seems to show 
an accurate fit.  This can be shown by excluding the values that show erratic 
variance. 
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Figure 35: MDBK MTT graph as shown in the results section but with the lowest 
eight concentrations excluded. 
These 4 data points show a coefficient of determination of 0.9378 showing that the 
line of regression is an accurate fit, especially in comparison for when it had to 
accommodate for the varied lower concentration values. 
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This only slightly changes the IC50 value down to 105.2 micrograms per ml (97.29-
113.9 with 95% CI) which has a very minimal effect on the actual result but narrows 
down the variance of the result substantially. 
Once more at the lower concentrations the data points indicate slight promotion in 
growth but once more the variance does drop below 100% cell viability so cannot be 
accurately determined. 
BEAS-2B: 
The BEAS-2B cell line had an IC50 of 82.01 (71.64 after outlier correction) 
micrograms per ml. This shows that the prawn GAGs are cytotoxic to this cell line. At 
the higher concentrations, some of the data points do show a significant difference 
from each other. 200 micrograms per ml shows significant difference with 50 
micrograms per ml and below indicating the concentration does have an effect on 
the cell viability of this cell line.  
Some of the data points in this data set do show a large variance (100 micrograms 
per ml) and could be further investigated for the removal of any potential outliers. 
When analysing the cell viabilities for this concentration, all the values fall between 
34.40% and 43.56% with the exception of a 100.57%. Therefore, this can be 
removed as an outlier. This lead to a new IC50 of 71.64 micrograms per ml being 
generated. This also vastly decreased the variance of the 100 microgram per ml data 
point making it significantly different from all the other data points compared to 
before when it shared no significant difference with the majority of data points.  
The coefficient of variation for the new outlier corrected graph was 0.4079. With 
visible inspection this will be due to overestimation of the lowest four concentrations 
and the underestimation of the four concentrations after that and the large variance 
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of all eight data points. The steep negative decline after 25 micrograms per ml can 
then not be accounted for due to the horizontal nature of the points before that. Once 
again, we can do further analysis to exclude these initial points. 
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Figure 36: BEAS-2B MTT cell viability graph of highest four concentrations. 
This graph gives an IC50 value of 72.00 micrograms per ml (60.51 – 85.50 with 95% 
CI). This has only minimally changed the IC50 value but has greatly narrowed down 
the variance range of the IC50 value to give a better determination of the true IC50 
value. The coefficient of determination of this new graph was 0.7524. This is due to 
the overestimation of the starting points and still does not indicate a good, close fit 
but is substantial improvement than the fit on the graph as a whole. 
Interestingly, unlike the other cell lines discussed and analysed so far, this is the first 
cell line to not reach 100% cell viability at any concentration even with the upper 
limits of variance of the data points. This contradicts the findings on K562 of 
promoted cell growth at the lower concentrations and suggests even at minimal 




MOLT-4 showed an IC50 of 4.627 micrograms per ml, this shows that the prawn 
derived GAGS are cytotoxic to the MOLT-4 cell line. The lowest six concentrations 
and highest six concentrations of GAGs showed a significant difference from each 
other. The two groups of six showed no significant differences within the group and 
within the groups they showed no correlation as well. 
Aldairi et al, 2018, when experimenting on MOLT-4 cell lines derived a result of 
approximately 1 microgram per ml when using cockle derived GAGs as opposed to 
prawn GAGs. The K562 findings previously discussed showed that on the K562 cell 
line prawn GAGs were 2.25 times less cytotoxic than the cockle equivalent. Using 
this cytotoxicity factor based upon the assumption it would be approximately similar 
across cell lines it would result in the IC50 being equivalent to roughly 2 micrograms 
per ml. This is in line with what Aldairi et al, 2018 discovered. 
Between 3.125 and 6.25 micrograms per ml of GAGs added, there is a massive 
increase in the cytotoxic effects of the GAGs. This descends from an average of 
96.9% cell viability down to 6.63% cell viability. This is a strong confirmation of the 
cytotoxicity of the prawn GAGs at the IC50 of 4.627 micrograms per ml. 
The coefficient of variation for this dataset was 0.9832. This implies a very close and 
accurate fit for the line of regression and when coupled up with visual observation 
and the very low variance of all the data points this is confirmed. 
Like K562, at the lower GAGs concentrations, cell viability is promoted above 100%. 
Even with the lower limits of the variance these results are still above the 100% cell 
viability threshold and therefore in very small concentrations the prawn GAGs may in 
fact promote cell growth and proliferation. 
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Inconclusive/Inaccurate Cell Lines: 
Both the Wehi-3 and SAOS-2 cell line were also tested under the same experimental 
conditions as the other cell lines but had some unexpected problems with the results 
so were not included in the results section but will be presented and further 
discussed in this subsection. 
The Wehi-3 cell line had a wide variance of results between the lowest concentration 
and 100 micrograms per ml in a similar fashion to the other cell lines when small 
concentrations were tested upon them. Between 100 micrograms per ml and 200 
micrograms per ml the 50% cell viability threshold was crossed and gave an IC50 of 
196 micrograms per ml. Due to the wide variance of all the data points however, the 
software used could not calculate a range using a 95% confidence interval.  
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Figure 37: Cell viability graph of Wehi-3 cells when various concentrations of prawn 
GAGs were added and recorded via the MTT assay. 
All the results below 100 micrograms per ml showed no significant difference, 
however the 200 micrograms per ml results did show a significant difference 
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compared to all the other data points. This could suggest that the IC50 may have 
been reached and may not just be an anomalous result. 
If this cell line was to be incorporated into the actual results, it shows the strongest 
inclination for lower concentrations of GAGs to promote cell proliferation as a 
substantial amount of data points find their mean above the 100% cell viability 
threshold. However all apart from one (3.125 micrograms per ml) have their lower 
variance points below 100% cell viability so this cannot again be accurately 
concluded. 
The only way to accurately confirm this would be to test higher concentrations to see 
if they followed suit with the results post 100 micrograms per ml. The reason this was 
not done however is because in a clinical setting, the concentrations higher than 
those tested in these experiments would be extremely difficult to actually use and 
administer effectively so the information gained from this would not be of much 
practical use. Furthermore, Wehi-3 is a mouse derived cell and the main target of 
this therapeutic would be human malignancies resulting in the further and prolonged 
testing of this cell line may not be a suitable use of resources and time. 
The SAOS-2 cell line was only able to be completed in duplicate due to 
contamination of the incubator in the research establishment contaminating the stock 
of SAOS-2 cells currently in culture at the time and the in progress MTT plates. The 
duplicate plates also had a very large variance for each data point meaning that 
there was no significant difference (apart from the lowest and highest concentrations 
of GAGs added) between any of the results and an accurate conclusion could not 
have been generated from this. 
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Figure 38: Cell viability of SAOS-2 cell line when various concentrations of prawn 
GAGs are added and results recorded via the MTT assay. 
An IC50 of 86.58 micrograms per ml was generated however with a 95% confidence 
interval the range was 44.69 – 255.1 micrograms per ml which branches between 
confirmation the GAGs are cytotoxic at the lower limit up to cytotoxicity at only an 
unusable concentration at the upper limit. 
To improve upon this and have this cell line in a useable format, a new batch of 
SAOS-2 cells would have to be cultured and repeated again in triplicate using the 
MTT assay. 
MTT Comparison: 
Individually, it has now been established if the prawn GAGs are cytotoxic to each 
respective cell line. By comparing the results between the cell lines and investigating 
similarities and differences, there may be a potential to identify some relationships 
between these cell lines regarding the cell viabilities and increasing our 
understanding of how the prawn GAGs work. 
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Table 16: A master table of all cell lines tested on and their corresponding cell 






















K562 51.98 23.10 RPMI Suspension Human 
MOLT
-4 
4.627 2.06 RPMI Suspension Human 
MDBK 105.4 46.84 DMEM Adherent Bovine 
U2OS 45.4 20.18 DMEM Adherent Human 
BEAS-
2B 
71.64 31.84 DMEM Adherent Human 
SAOS
-2* 
86.58 38.48 DMEM Adherent Human 
Wehi-
3* 
196 87.11 DMEM Suspension Mouse 
(*) indicates these cell lines were not used in results due to factors discussed in a 
previous subsection 
(**) A 2.25 cytotoxcity difference was shown between cockle and prawn GAGs on 
the K562 cell line. The hypothesis for this column is based upon the assumption the 
two differently sourced GAGs have a proportionate effect across the cell lines. 
The first factor to be investigated is a factor that only effects the cells in an in-vitro 
setting which is the growth medium. The two growth mediums used in this 
investigation were RPMI and DMEM.  
When excluding the two cell lines that were not included in the results, both the 
growth medium and the adherent/suspension characteristic contain the exact same 
cell lines so cannot be individually investigated and were therefore grouped together 






































































Figure 39: A graph of IC50 versus the cell characteristics. 
The RPMI/Suspension cell lines (henceforth group 1) and the DMEM/Adherent cell 
lines (henceforth group 2) have an average IC50 of 28.3 micrograms per ml and 74.1 
micrograms per ml respectively.  Using an unpaired t-test to investigate whether 
there is a significant difference or not gives a p value of 0.2065. As this value is 
greater than 0.05 (which is the standard threshold for t-tests) it can be concluded 
that the null hypothesis of no significant difference between the two groups is true. 
If the questionable results of the (*) cell lines are used, we can separate the results 
into adherent and suspension independently due to the Wehi-3 cell line being 
suspension and cultured in DMEM media. A t-test of these two groups generates a p 
value of 0.8959 which strongly agrees with the null hypothesis that there is no 
significant difference between the groups. 
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A one way ANOVA was conducted of all five groups generated on the graph which 
gave a p value of 0.6627. Again, this indicates that the null hypothesis of no 
significant difference is true between all the groups. 
This is a very basic statistical analysis that is limited by a few factors. To begin with, 
the groups are unbalanced. There is a larger amount of adherent cell lines and cell 
lines cultured in DMEM media. Secondly, this is an extremely small data set. In 
group 1 there is only two data points and in group 2 there is only three. The 
smallness of the sample size will not accommodate for any outliers or anomalous 
cell lines that may not fit the overall trend and therefore may be a limiting factor of 
this analysis. The other factors not accounted for are not evenly weighted between 
the two groups either. Group 1 only contains human leukemia and group 5 only 
contains leukemia in general. Group 2 contains both animal cell lines and healthy 
cell lines which may affect the results. These factors were further investigated below, 
however due to the uneven spread of these factors between the groups they may 
limit this statistical analysis. 
To investigate the difference between animal and human sourced cell lines the (*) 
will need to be incorporated otherwise there will only be a solitary animal sourced 






























Figure 40: IC50 mean and range of cell lines when grouped based upon the sourcing 
of the cells. 
When grouped via this way, the human sourced cell lines have a mean IC50 of 52.05 
micrograms per ml and the animal sourced cell lines have an IC50 of 150.7 
micrograms per ml. A two-tailed t-test generates a p value of 0.0318 which rejects 
the null hypothesis of no siginificant difference and suggests there is a significant 
difference between the two groups. This is further illustrated by the graph as the 
upper range of the human sourced cell lines does not overlap with the lower limit of 
the animal sourced cell lines. 
Once more, this statistical analysis is limited by the sample size. The animal group 
only had two data points for reference in comparison to the five data points of the 
human sourced cell lines. Also, this data analysis had to incorporate the two (*) cell 
lines which cannot be confirmed as accurate results. This may impact the accuracy 
of this analysis as a consequence however both groups contained one of these 
questionable results each which may balance it out. 
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The final and arguably most important analysis/comparison is comparing the healthy 



































Figure 41: Comparing the mean and range IC50’s of the investigated cell lines when 
grouped as healthy and cancerous. 
The mean of the healthy cell lines was 88.52 micrograms per ml in comparison to the 
mean IC50 of the cancerous cell lines being 76.92. This suggests that cancerous 
cells are more responsive to the cytotoxic properties of the prawn GAGs. However, a 
two tailed t-test gives a p value of 0.8415 which accepts the null hypothesis of there 
being no siginificant difference between the two groups.  
However, if we exclude the animal cells and the rejected SAOS-2 cells for being 





































Figure 42: IC50 mean and range of human healthy and cancerous cells when prawn 
GAGS are added. 
As shown above, the IC50 of the healthy human cell line (BEAS-2B) does not fall 
within the range of the cancerous cell lines and is over double (71.64 compared to 
34.00 micrograms per ml) the mean IC50 of the cancerous cell lines. The t-test does 
however generate a p value of 0.3316 which accepts the null hypothesis of no 
significant difference however with the healthy cell line group only having one data 
point it cannot be decisively concluded either way. 
This analysis is very limited due to only one human healthy cell line being 
investigated. It does however suggest that cancerous cells are more responsive to 
the cytotoxic properties of the prawn GAGs than healthy human cells are. This would 
need to be confirmed with a larger sample size. 
Ideally, a final comparison would be made of cancerous cell lines against their direct 
healthy counterpart to determine on an individual basis based upon the in vitro 
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results if the prawn GAGs could be a potential effective treatment. As the main 
hypothesised use of the marine GAGS would be to treat leukemia, the K562 and 
MOLT-4 results should be investigated against healthy bone marrow cells such as 
human bone marrow mononuclear cells (BMNC’s) or HEL 92.1.7 and AR230-s. 
Cell Lines: 
During this study a plethora of cell lines were used. This subsection will outline what 
the cell lines were and delve into a little bit of detail about them. 
The primary focus of this study was on the cell line K562.  K562 is a human 
erythroleukemic cell line as it expresses glycophorin on the surface, glycophorin is 
found exclusively in human bone marrow on erythroid cells (Andersson, Nilsson and 
Gahmberg, 1979). As shown by the age of the protocol cited, this cell line was 
discovered long ago and has been heavily researched since. K562 is a suspension 
cell line which was grown in RPMI-1640 media with penicillin and streptomycin 
added to prevent infection and bovine fetal serum and l-glutamine also added. These 
cells were cultured at 37 degrees Celsius in a cell culture incubator with carbon 
dioxide injection, as was all the cells to be further discussed. From investigation, the 
optimum incubation time was found to be 2-3 days before needing to be split when 
cultured in a T25 flask. These cell lines were both cultured as a parental cell line and 
a Cisplatin resistant cell line. These cells were found to be the most robust and easy 
to culture during this investigation. 
MOLT-4 is a human acute lymphoblastic leukemia cell line which like K562, was also 
again cultured in suspension (Ma et al, 2014). These were also cultured in the same 
media as the K562 cells and once again had an optimum passage time of 3-4 days. 
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The only noticeable difference is that this cell line was a little less robust and was 
more prone to death if mishandled or over-cultured. 
BEAS-2B are human bronchial epithelial cells (KInnula et al, 1994) that are adherent 
cells cultured in DMEM (Dulbecco’s Modified Eagle’s Medium) again added with 
10% fetal bovine serum and streptomycin and penicillin. This time l-glutamine was 
not needed to be added as the medium came with it present. The BEAS-2B cells 
required on average 4-5 days to reach confluence in a T25 flask. These were the 
only healthy human cell lines readily available at the research establishment within 
the timeframe this research was undertaken. 
Another strain of healthy cells was also used, albeit from an animal source. MDBK 
(adult bovine kidney) are a cell line that is capable of continuous cultivation as 
discovered and published in 1958 by Madin and Darby. Once again they were 
cultured in DMEM and had an optimum time of confluence of approximately 4-5 
days. Although healthy animal cells are not directly relevant to a therapeutic 
potentially designed to treat human derived leukemia, by investigating its’ properties 
on healthy and malignant animal cells we may be able to help further understand the 
capabilities and mechanisms of action of the marine derived GAGs. 
Wehi-3 is a mouse derived cancer cell line from the peripheral blood so was 
investigated to see if the efficacy of the therapeutic varied when used on an animal 
derived leukemia.  Wehi-3 is also an interesting cell line as it secretes interleukin 1 
and colony-stimulating factors (Booth, Prestidge and Watson, 1983). As it is a 
leukemia cell line, it is cultured in suspension but this time unlike the human 
equivalent, it is cultured in DMEM. Like K562 however, it was ready for passage 
approximately every 3 days. 
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U2OS cells are a human osteosarcoma cell line and was one of the first generated 
cell lines and is widely used in biomedical research (Niforou et al, 2008). Once again 
this was an adherent cell line cultured in DMEM. As blood cells develop from stem 
cells in the bone marrow, this cancer was of interest to investigate to see if there 
were any similarities with the therapeutic response compared with K562 and MOLT-
4 leukemia.  
Finally, SAOS-2 were also used which once again is a human osteosarcoma cell 
line, with this one recorded in publications as showing osteoblastic features 
(Prideaux et al, 2014). This once more was an adherent cell line grown in DMEM. 
This cell line was of relevant interest for the same reasons as U2OS and also 
because now intra-malignancy comparisons could be made between SAOS-2 with 
U2OS and K562 with MOLT-4 to see if there was therapeutic variation between the 
two cell lines when they are both from the same malignancy. 
MTT Limiting Factors: 
The MTT assay as previously discussed in this paper is persistently used across 
research laboratories around the world. However, it does not come without its’ 
limitations.  
As this study was conducted over a year, the stability of the MTT reagent could have 
been a limiting factor that may have potentially affected the results. The MTT reagent 
is light-sensitive and the batch used in this study was frequently opened and used 
throughout the year by many researchers in the establishment. This means that the 
time it was left in the light cannot be quantified or controlled as it was used by a wide 
range of differently skilled researchers ranging from undergraduate students to post-
doctoral researchers.  
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To improve upon this, if financially viable, the experiments could be repeated and 
each time a small one use batch of MTT reagent could be prepared in a dark room, 
negating the destabilising factor of time and light exposure. 
Solubilisation of the formazan crystals was not always uniform and consistent which 
may have led to false absorbance readings. One way to improve upon this would be 
to perform the MTS assay instead which produces water-soluble formazan and 
removes the need for solubilising the final product (Tonder, Joubert and Cromarty, 
2015). 
At the lower end of chemotherapeutic pharmaceutical concentration added to the 
wells, the results became very inconsistent and had great variation. This may be due 
to the sensitivity of the MTT assay itself. In a study conducted by Tonder, Joubert 
and Cromarty in 2005, they found that the SRB (sulforhodamine B) assay showed 
greater sensitivity and a smaller variation than the MTT assay. Potentailly to improve 
upon the results this assay could be used in future studies. 
Protein Lysis: 
The BSA (Bovine serum albumin) standard curve as a standard is effectively used to 
determine the total amount of protein produced from the cell lysis procedure. This is 
of particular importance as the cell lysate is used in both the SDS-PAGE analysis 
and for the affinity chromatography, so a sufficient amount of protein is required for 
detection in both of these methods, especially as there is no prior knowledge as to 
how much protein is separated into each fraction via affinity chromatography. The 
amount of protein present in a sample also determines which stain to use on the 
SDS-PAGE gels as different staining methods have different sensitivities. 
Coomassie blue for instance can detect microgram amounts of protein whereas 
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silver stain and Oriole fluorescent stain can detect nanogram amount of proteins on 
an SDS-PAGE gel.  
There is an issue with one step in the cell lysis protocol used which could be 
improved upon. If incorrect cooling is applied during the sonication stage, localised 
heating could occur which could potentially lead to protein denaturation and 
aggregation. This would be detrimental to the affinity chromatography as if the 
protein that binds to the GAGs is sufficiently denatured it will not bind to the 
stationary phase in the column and will then elute with the first buffer wash causing a 
lower elution on the subsequent salt washes. This may give overall lower 
absorbance readings when analysed for protein concentration in the later fractions 
which would suggest less cellular proteins undergo strong binding with the GAGs. 
Freeze-thaw cell lysis (Tansey, 2006) with careful temperature control when thawing 
could be a safer method for this procedure. Another alternative could be liquid 
homogenization (Myers, Rwkhadevi and Ramesh, 2011) if financial situation allows. 
SDS-PAGE Results: 
The SDS-PAGE results when stained with the Oriole fluorescent stain showed that 
there was multiple proteins that had high-specific binding to the immobilised GAGs in 
the stationary phase. Using a protein ladder as a rough size estimate (limitations 
discussed in the next sub-section) these proteins are shown to be between 2-10kDA. 
This is extremely small for a cellular membrane protein which was what was 
hypothesised to be the mechanism of action of the GAGs.  
The SDS-PAGE gels show that in the first lane (total cell lysate) that there was a lot 
of excess run off of the cellular proteins which in theory should indicate that the 
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immobilised GAGs were saturated with binding complexes successfully and virtually 
all the available GAGs should have been bound to cellular proteins. 
Wells 2-6 show that via the phosphate buffer wash that there was still excess 
proteins unbound and subsequently washed out. The volume of protein bands 
present in these wells suggest that there was not a lot of cellular proteins bound to 
the immobilised GAGs.  
Wells 7-11 show that there was some non-specific binding between the cellular 
proteins and the GAGs as the low salt concentration interfered with this and negated 
it causing the proteins to detach and wash off 
Wells 12-16 with the medium salt concentration shows that nearly all non-specific 
binding was removed with the low salt concentration, proteins may still have been 
removed by this wash just in minimal concentration.  
Wells 17-21 shows a few remaining bands which represent the proteins that had 
high-specific binding which was negated by the high concentration salt wash. In 
theory these are the proteins that interact with the GAGs and cause them to have 
their cytotoxic action. 
Highly specific binding proteins: 
The low molecular weight of the highly specific bound proteins, according to the 
initial hypothesis, is a peculiar result as cellular membrane proteins are very rarely 
this low in molecular weight.  
To investigate whether or not it is a cellular membrane protein, a cellular membrane 
preparation could be performed.  
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An efficient way to undertake this would be to use the ThermoFisher Mem-PER plus 
kit. This method works first by washing cultured cells in 3 millilitres of the cell wash 
supplied and and centrifuging, followed by a 1.5 millilitre cell wash and 
centrifugation, followed by a 0.75 millilitre suspension in permeabilisation buffer and 
centrifugation after a 10-minute incubation at 4 degrees Celsius. This is finally 
centrifuged at 4 degrees Celsius at 16000 xg and the supernatant collected (Cirbaite, 
Meier and Siurkus, 2013). This is then resuspended in 0.5 millilitres of the 
solubilisation buffer and incubated at 4 degrees Celsius for 30 minutes with constant 
agitation. Finally, this is centrifuged for 15 minutes at 4 degrees Celsius at 16000 xg 
and the supernatant extracted which should contain isolated cellular membrane 
proteins. These can then be added to the affinity column as done in this overarching 
study in place of the total cell lysate. 
This should show less protein present between wells 1-16 as the intracellular 
proteins are no longer present. If the results for wells 17-21 are the same then this 
indicates the result is a very small membrane protein, if not, a different mechanism of 
action may be in place that was not hypothesised about. 
One such mechanism may be endocytosis. This is where the cell engulfs the 
external agent (GAG in this case) and internalizes it. This would mean that the 
protein bands then represent an intracellular protein that binds to the GAGs and 
stars a cascade of chemical signalling that induces cell death. 
Another interesting factor of the SDS-Gel PAGE results is that there is more than 
one protein band which means there is definitely more than one protein that the 
GAGs are binding to. To investigate if there is more than two you would have to 
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further separate the two present bands in wells 17-21 via another method such as 
2D electrophoresis.  
This could indicate the GAGs work in a multi-faceted approach and need a 
combination of proteins to be present to initiate cytotoxic action. On the other hand, 
just because the GAG binds to the proteins does not necessarily mean it is indicative 
of being the mechanism of action. In vivo, the GAG may not even be able to bind to 
that protein due to lack of access to it and may only be binding to it due to the 
experimental conditions of having the mammalian cell lysed and all intracellular and 
membrane proteins accessible. 
SDS-PAGE Calibration: 
SDS-PAGE is a complex protocol that has many different variables as part of it. 
Each variable can be changed and fine-tuned to have a plethora of effects on the 
experiment. A major variable is the type of stain used to visualise the separated 
proteins in the SDS-PAGE gel. Coomassie Blue is the common standard for staining 
SDS-PAGE gels. Briefly, this protocol uses a fixing solution followed by incubation in 
Coomassie blue stain to stain the entire gel blue finally followed by incubation in a 
destaining solution which destains the background faster than the protein bands 
leaving the protein bands a visible blue as the background destains to a lighter 
blue/transparent colour. 
Silver stain is another commonly used staining method for SDS-PAGE gels. This 
method is more expensive per use but also more sensitive to proteins present. It 
uses a sensitising solution before staining and a developer solution after staining to 
further visualise present proteins. This protocol doesn’t require background 
destaining as the developer solution ‘darkens’ the protein bands faster than the 
98 
 
background of the gel. Once the protein bands are visible a stopping solution is used 
to stop any further development. 
Oriole fluorescent gel stain by BioRad is a simple yet expensive alternative way to 
stain the gels and more sensitive than the previous two stains discussed. This stain 
only requires incubation in a dark box then excitation underneath a UV lamp 
containing an ethidium bromide filter. This causes the bands to fluoresce and be 
easily imaged, it also requires no background destaining and once stained, the gels 
can be stored in their entirety for up to 6 months.  
Stain Protein detection range Background destaining 
Coomassie Blue  Yes 
Silver Stain  No 





Over the course of this investigation, all three of these staining protocols were used 
to varying degrees of success. From a chronological perspective in relation to this 
investigation. Coomassie blue was the first staining procedure to be investigated. 
When the gels with the applied affinity fractions were stained, it appeared that there 
was a negative result. The two most common probabilities from this were either a 
faulty stain or the protein bands being under the limit of detection for coomassie 
blue. To investigate this, bacterium lysed with BugBusterTM was used in place of the 




Figure 43: Lysed bacterium stained with Coomassie Blue. 
As illustrated by the above figure, the lysed bacterium were visualised fine with the 
Coomassie blue stain, suggesting it was a limit of detection issue. This lead to the 
next step of using silver stain to visualise the protein bands. 
 
Figure 44: SDS-PAGE gel loaded with affinity fractions 1-11 stained with silver 
lysate. 
As shown by the figure above, fraction 1 which is where the total cell lysate was 
added to the column shows a very strong positive result which was to be expected. 
However, every fraction after that (5 times phosphate buffer wash and 5 times low 
salt concentration wash) shows negligible results which goes against the theory of 
this experiment. To investigate if it was a limit of detection issue again, the gel was 




Figure 45: Over-developed SDS-Page gel with silver stain. 
Overdeveloping the gel potentially shows present proteins in fractions 2-11 which is 
to be as of expected, however the lack of clarity of the gel once over-developed 
results in an unusable gel/result for scientific purposes. As once again the most 
suitable hypothesis is the limit of detection of the proteins is limiting this experiment, 
the next stage was to use Oriole fluorescent stain. 
Using the Oriole fluorescent stain lead to the clear results as seen in the results 
section prior to this. However, there was still an issue with the fluorescent stain that 
wasn’t rectified. The only molecular weight marker available in the research 
establishment only worked with visible protein stains such as Coomassie Blue and 




Figure 46: Molecular weight ladder with Oriole stain under the visible protein setting of 
the gel imager. 
 
Figure 47: Molecular weight ladder with Oriole stain under the fluorescent protein 
setting of the gel imager. 
As shown above, the protein ladder is only visible and usable when used on the 
visible protein setting of the gel imager which results in the fluorescent proteins not 
being visible on the gel. Due to financial limitations, a UV molecular weight ladder 
was unable to be obtained and a not ideal workaround was used to obtain a rough 
estimate of protein sizes. Using pre-cast gels from the exact same batch and under 
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the exact same experimental conditions even down to small details such as using 
the exact same gel tank. The experiment was repeated for the affinity fractions and a 
molecular weight marker and the molecular weight marker was super-imposed onto 
the gel to give a rough estimate of the size of the proteins isolated. 
 
Figure 48: SDS-PAGE gel stained with Oriole fluorescent stain and superimposed 
molecular weight marker to roughly estimate the separated proteins in the affinity 
fractions after the high salt concentration wash (2M NaCl in phosphate buffer). 
Affinity Chromatography: 
For successful separation/purification of the total cell lysate and to isolate the highly 
specific binding proteins that had bound to the GAGs from the less specific binding 
proteins, differing salt concentrations were used (theory discussed in the affinity 






Table 17: A brief overview of the contents of each affinity fraction and the reasoning 
behind the contents of the mobile phase. 
FRACTION 
NUMBER 















2M NaCl in 
phosphate 
buffer 
Reason To allow 
proteins in 
cell lysate 





































As evidenced by the protein absorbance spectra, these various salt concentrations 
did in fact result in separation of the bound proteins to the GAGs. Having five 
fractions for each addition of buffer allowed the peak elution for each section to be 
captured within the five repeats and allowed for minimal overlap between the 
different additions of the buffers. 
The buffer wash for fractions 2-6 was essential as evidenced by the SDS-Gel images 
as these gave a positive result and showed up proteins which would have been 
incorporated and interpreted as low specific binding proteins if not washed off first. 
A stronger NaCl concentration potentially could have been applied afterwards to 
completely remove and specifically bound proteins and to check for their presence, 
however based upon the results it seems like the 2M NaCl concentration did a 
sufficient job and any stronger salt concentration would have been overkill. 
The sham column was employed as a negative control with no GAGs linked to the 
stationary phase. This gives a negative control as it accounts and illustrates any 
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direct binding between the total cell lysate and the affi-gel 10 beads. There is no 
GAGs present for electrostatic bonds to be formed with by the total cellular proteins 
so in theory there should be a close to basal level of binding as the only binding will 
be non-specific binding directly to the affi-gel 10 beads which should be removed by 
the low salt concentration wash. 
By analysing both absorbance spectra for the parental and cisplatin resistant K562 
cell lines it is evident that the affinity chromatography was successful in the 
separation of the total cell lysate. The initial peak and subsequent wash with 
phosphate buffer alone shows that a substantial amount of the total cell lysate does 
not bind to the GAGs present in the stationary phase as the collected fractions show 
a high level of protein present that has run through.  The introduction of a weak salt 
concentration shows an elution of proteins once more. This indicates that there was 
weak/non-specific binding between some of the total cell lysate and the GAGs that 
was disrupted by this salt concentration. Another increase in the salt concentration of 
the mobile phase shows a small elution of proteins in the parental cell line column 
and minimal elution in the cisplatin resistant cell line column. This indicates there 
may be a few proteins present in the cell lysate that incur slightly stronger bonding 
with the GAGs. When a high salt concentration is put through both columns a small 
protein elution is once more recorded. This indicates that between the GAGs and the 
total cell lysate there was some strong, specific binding with the GAGs linked to the 
stationary phase. 
However, these absorbance spectra do not account for anything without comparison 
to a ‘sham’ column that has no GAGs linked to the stationary phase. Referring to the 
sham column spectra, it is shown that a much higher emission is recorded for the 
initial peak when a phosphate buffer is put through the column. This indicates that a 
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lot more of the total cell lysate has eluted from the column and not bound to the 
stationary phase. There are still very slight absorbance recordings for all three 
different salt concentrations, especially with the strongest salt concentration which 
borders on a baseline reading. This shows that when no GAGs are present, there is 
little to none strong binding of total cell lysate to the stationary phase and a lot less 
weak binding between the cell lysate and the stationary phase. This is due to no 
GAGs being present for electrostatic bonds to be formed with the cellular proteins 
and to be affected by ionic change due to the differing NaCl concentrations. 
The overall outcome of this result is that potentially in the fractions after the final 
strong salt wash, there is the cellular protein that binds to the GAGs which the 
discovery of could lead to more in depth investigation into the mechanisms of GAG 
action in cancer cell lines and help to shine some light on why marine derived GAGs 
have anti-cancer activity but mammalian ones do not. 
To further analyse this, these fractions could be analysed with a multitude of further 
analytical and purification techniques. These include gel chromatography to further 
purify the fractions which has a more precise separation. Another further analytical 
technique could be running the fractions on an SDS-PAGE gel to visualise which cell 
lysate proteins are in each fraction in comparison to the total cell lysate. The bands 
visualised after staining in the fractions after the strong salt wash could then be cut 
out and mass spectrometry performed on them to find out which cellular protein(s) is 







Due to the nature of this study and the novel results produced, a plethora of future 
research paths have potentially opened to take this research further.  
 The discovery of prawn GAGs being a much simpler mixture when extracted, an 
investigation in to other marine sources could develop from there. One such 
approach could involve investigating the phylogeny of prawns and seeing any other 
marine species sharing a close evolutionary history also share a simpler GAG 
extract. This could be of particular interest when investigating the reasoning behind 
marine GAGs containing anti-cancer activity with mammalian GAGs not as a simpler 
complex would be easier and more efficient to analyse and notice differences in. 
Prawns belong to the class Malacostraca which contains approximately 30,000 
individual species (Thorp and Rogers, 2016). With regard to taxonomic classification, 
this could be too broad and will more than likely be far too impractical to investigate, 
so another approach may be to look further down the taxonomic classifications and 
investigate species in the same genus and potentially family. The relevant taxonomic 
family for this would be Penaeidae. 
Another approach to further study could be to test the anti-cancer activity of the 
various sourced GAGs on other cancer cell lines. This could be facilitated before or 
after identifying the binding protein in the cancer cell for the GAGs that gives the 
GAG anticancer activity. If it is after, a more efficient approach of testing GAGs on 
other cancer cells could be undertaken to see if it still shows anticancer activity on 
these. This would once again be done via the MTT assay and should be compared 
to a known cell line that has been shown to be responsive to GAGs (MOLT4 or K562 
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as used in the Aldairi et al (2018) paper would be the most efficient at the time of 
writing). 
If time and resources were not a limiting factor to this study, affinity chromatography 
could be performed on both the cancer cell lines and the healthy cell lines to see if 
there is a difference in the proteins present in the final fractions of the affinity column. 
If there is a different protein present in the cancer cell line compared to the healthy 
cell line then this could suggest that that protein is specific to when the cell line is 
cancerous and could be specifically targeted therapeutically.  
The study conducted in this research was mainly aimed an investigating the 
cytotoxicity of the chemotherapeutic derived from marine sources. Another property 
of the chemotherapeutic that could be further investigated is the anti-proliferative 
properties of the GAGs.  The HGF-MET axis, which contributes to tumour 
progression in various cancers and accelerates cellular invasion linked with tumour 
metastasis (Cecchi, Rabe and Bottaro, 2010), is currently being investigated by 
using synthetic GAGs to inhibit this axis at the University of Salford. Although they 
are showing no cytotoxic effects, positive anti-proliferative results have been 
obtained via the scratch assay on the ‘sonic hedgehog’ (SHH) line of 
medulloblastoma cells. The scratch assay consists of plating adherent cells in a well 
and using a sharp point (usually a pipette tip), scratching a line through the plated 
cells. The cells are regularly imaged using a microscope linked up to imaging 
software at regular intervals and the average width of the scratch is measured 
(Liang, Parkand Guan, 2007). This can then be converted into a percentage of 
distance closed and be illustrated as a variable over time and used comparatively 
with other differing experimental conditions such as concentration of 
chemotherapeutic agent added. 
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However, there are two main issues with this for this investigation, the most sensitive 
cancer cells and the main focus of this study (K562 and MOLT-4) are both 
suspension cells. Additionally, this study has found that in these cells lines and many 
others, an IC50 can be reasonably achieved and therefore the marine derived GAGs 
are cytotoxic.  
The first and second issue can both be simultaneously be addressed by using 
different cancer cell lines. An initial and scientifically interesting step to take would be 
to first test the marine derived GAGs on the SHH DAOY medulloblastoma cells the 
synthetic GAGs were tested on using the MTT assay to see if there is any 
cytotoxicity. If not, then the scratch assay can be performed using the marine derived 
GAGs and can be compared to the synthetic GAGs. Alternatively, the adherent 
cancer cell lines that an IC50 was not reached at could be tested on via the scratch 
assay as even though the marine GAGs will not be cytotoxic, a chemotherapeutic 
that negates metastasis would still be very beneficial. 
For the cancer cell lines that do achieve an IC50 with the marine derived GAGs, it 
may be possible to conduct the scratch assay at a lower concentration such as the 
IC10 to limit the death of the cancer cells and investigate and anti-proliferative 
properties. 
Conclusion: 
To conclude, this study has shown that cockles are not the only marine source of 
glycosaminoglycans that have anti-proliferative properties in vitro. It has identified a 
range of cancerous cell lines that a reasonable IC50 can be achieved on and has 
begun to establish a relationship that the marine derived GAGs are less cytotoxic on 
healthy cells than they are on cancerous cells.  
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This study has also successfully isolated and illustrated the potential cellular proteins 
involved in the binding/activity of the GAGs via affinity chromatography and SDS-
PAGE.  
Furthermore, this study has also performed structural and compositional analysis on 
the prawn derived GAGs and used this with already established literature to identify 
differences between prawn, cockle and mammalian derived GAGs which may begin 
to explain the differences, and in the case of mammalian GAGs, lack of anti-
proliferative activity.  
This study could provide a solid foundation for multiple future studies into the use of 
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